<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Atherectomy for peripheral arterial disease - Wardle, BG - 2020 | Cochrane Library</title> <meta content="Atherectomy for peripheral arterial disease - Wardle, BG - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006680.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Atherectomy for peripheral arterial disease - Wardle, BG - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006680.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006680.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Atherectomy for peripheral arterial disease" name="citation_title"/> <meta content="Bethany G Wardle" name="citation_author"/> <meta content="North Bristol NHS Trust" name="citation_author_institution"/> <meta content="Graeme K Ambler" name="citation_author"/> <meta content="Rami W Radwan" name="citation_author"/> <meta content="Cardiff University" name="citation_author_institution"/> <meta content="Robert J Hinchliffe" name="citation_author"/> <meta content="Christopher P Twine" name="citation_author"/> <meta content="chris_twine@hotmail.com" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD006680.pub3" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/09/29" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006680.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006680.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006680.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Coronary Syndrome [mortality]; Angioplasty, Balloon [*methods, mortality]; Atherectomy [*methods, mortality]; Cause of Death; Heart Failure [mortality]; Peripheral Arterial Disease [mortality, *therapy]; Randomized Controlled Trials as Topic; Stents" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006680.pub3&amp;doi=10.1002/14651858.CD006680.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="UiM8QuvV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006680\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006680\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fa","fr","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006680.pub3",title:"Atherectomy for peripheral arterial disease",firstPublishedDate:"Sep 29, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UiM8QuvV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006680.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006680.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006680.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006680.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006680.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006680.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006680.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006680.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006680.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006680.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3612 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006680.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full#CD006680-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full#CD006680-sec-0069"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full#CD006680-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full#CD006680-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full#CD006680-sec-0013"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full#CD006680-sec-0014"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full#CD006680-sec-0038"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full#CD006680-sec-0063"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/appendices#CD006680-sec-0074"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/table_n/CD006680StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/table_n/CD006680StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Atherectomy for peripheral arterial disease</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/information#CD006680-cr-0004">Bethany G Wardle</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/information#CD006680-cr-0005">Graeme K Ambler</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/information#CD006680-cr-0006">Rami W Radwan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/information#CD006680-cr-0007">Robert J Hinchliffe</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006680.pub3/information#CD006680-cr-0008"><i class="icon corresponding-author fa fa-envelope"></i>Christopher P Twine</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/information/en#CD006680-sec-0079">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 29 September 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006680.pub3">https://doi.org/10.1002/14651858.CD006680.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006680-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006680-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006680-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006680-abs-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006680-abs-0006">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006680-abs-0001" lang="en"> <section id="CD006680-sec-0001"> <h3 class="title" id="CD006680-sec-0001">Background</h3> <p>Symptomatic peripheral arterial disease (PAD) has several treatment options, including angioplasty, stenting, exercise therapy, and bypass surgery. Atherectomy is an alternative procedure, in which atheroma is cut or ground away within the artery. This is the first update of a Cochrane Review published in 2014. </p> </section> <section id="CD006680-sec-0002"> <h3 class="title" id="CD006680-sec-0002">Objectives</h3> <p>To evaluate the effectiveness of atherectomy for peripheral arterial disease compared to other established treatments. </p> </section> <section id="CD006680-sec-0003"> <h3 class="title" id="CD006680-sec-0003">Search methods</h3> <p>The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Allied and Complementary Medicine (AMED) databases, and the World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers to 12 August 2019. </p> </section> <section id="CD006680-sec-0004"> <h3 class="title" id="CD006680-sec-0004">Selection criteria</h3> <p>We included all randomised controlled trials that compared atherectomy with other established treatments. All participants had symptomatic PAD with either claudication or critical limb ischaemia and evidence of lower limb arterial disease. </p> </section> <section id="CD006680-sec-0005"> <h3 class="title" id="CD006680-sec-0005">Data collection and analysis</h3> <p>Two review authors screened studies for inclusion, extracted data, assessed risk of bias and used GRADE criteria to assess the certainty of the evidence. We resolved any disagreements through discussion. Outcomes of interest were: primary patency (at six and 12 months), all‐cause mortality, fatal and non‐fatal cardiovascular events, initial technical failure rates, target vessel revascularisation rates (TVR; at six and 12 months); and complications. </p> </section> <section id="CD006680-sec-0006"> <h3 class="title" id="CD006680-sec-0006">Main results</h3> <p>We included seven studies, with a total of 527 participants and 581 treated lesions. We found two comparisons: atherectomy versus balloon angioplasty (BA) and atherectomy versus BA with primary stenting. No studies compared atherectomy with bypass surgery. Overall, the evidence from this review was of very low certainty, due to a high risk of bias, imprecision and inconsistency. </p> <p>Six studies (372 participants, 427 treated lesions) compared atherectomy versus BA. We found no clear difference between atherectomy and BA for the primary outcomes: six‐month primary patency rates (risk ratio (RR) 1.06, 95% confidence interval (CI) 0.94 to 1.20; 3 studies, 186 participants; very low‐certainty evidence); 12‐month primary patency rates (RR 1.20, 95% CI 0.78 to 1.84; 2 studies, 149 participants; very low‐certainty evidence) or mortality rates (RR 0.50, 95% CI 0.10 to 2.66, 3 studies, 210 participants, very low‐certainty evidence). One study reported cardiac failure and acute coronary syndrome as causes of death at 24 months but it was unclear which arm the participants belonged to, and one study reported no cardiovascular events. </p> <p>There was no clear difference when examining: initial technical failure rates (RR 0.48, 95% CI 0.22 to 1.08; 6 studies, 425 treated vessels; very low‐certainty evidence), six‐month TVR (RR 0.51, 95% CI 0.06 to 4.42; 2 studies, 136 treated vessels; very low‐certainty evidence) or 12‐month TVR (RR 0.59, 95% CI 0.25 to 1.42; 3 studies, 176 treated vessels; very low‐certainty evidence). All six studies reported complication rates (RR 0.69, 95% CI 0.28 to 1.68; 6 studies, 387 participants; very low‐certainty evidence) and embolisation events (RR 2.51, 95% CI 0.64 to 9.80; 6 studies, 387 participants; very low‐certainty evidence). Atherectomy may be less likely to cause dissection (RR 0.28, 95% CI 0.14 to 0.54; 4 studies, 290 participants; very low‐certainty evidence) and may be associated with a reduction in bailout stenting (RR 0.26, 95% CI 0.09 to 0.74; 4 studies, 315 treated vessels; very low‐certainty evidence). Four studies reported amputation rates, with only one amputation event recorded in a BA participant. We used subgroup analysis to compare the effect of plain balloons/stents and drug‐eluting balloons/stents, but did not detect any differences between the subgroups. </p> <p>One study (155 participants, 155 treated lesions) compared atherectomy versus BA and primary stenting, so comparison was extremely limited and subject to imprecision. This study did not report primary patency. The study reported one death (RR 0.38, 95% CI 0.04 to 3.23; 155 participants; very low‐certainty evidence) and three complication events (RR 7.04, 95% CI 0.80 to 62.23; 155 participants; very low‐certainty evidence) in a very small data set, making conclusions unreliable. We found no clear difference between the treatment arms in cardiovascular events (RR 0.38, 95% CI 0.04 to 3.23; 155 participants; very low‐certainty evidence). This study found no initial technical failure events, and TVR rates at six and 24 months showed little difference between treatment arms (RR 2.27, 95% CI 0.95 to 5.46; 155 participants; very low‐certainty evidence and RR 2.05, 95% CI 0.96 to 4.37; 155 participants; very low‐certainty evidence, respectively). </p> </section> <section id="CD006680-sec-0007"> <h3 class="title" id="CD006680-sec-0007">Authors' conclusions</h3> <p>This review update shows that the evidence is very uncertain about the effect of atherectomy on patency, mortality and cardiovascular event rates compared to plain balloon angioplasty, with or without stenting. We detected no clear differences in initial technical failure rates or TVR, but there may be reduced dissection and bailout stenting after atherectomy although this is uncertain. Included studies were small, heterogenous and at high risk of bias. Larger studies powered to detect clinically meaningful, patient‐centred outcomes are required. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006680-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006680-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006680-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006680-abs-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006680-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD006680-abs-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006680-abs-0008">Bahasa Malaysia</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006680-abs-0002" lang="en"> <h3>Atherectomy for peripheral arterial disease</h3> <p><b>Background</b> </p> <p>Peripheral arterial disease is a narrowing or blockage of the arteries in the legs. People with this condition can experience pain on walking, pain at rest, or leg ulceration due to poor blood supply. Treatment options are: surgery, using a blood vessel or graft to bypass the narrowed or blocked section of the artery; balloon angioplasty, when a deflated balloon is passed into the narrowing at the end of a wire, then blown up to stretch the artery; and stenting (used in addition to balloon angioplasty), which holds open the balloon‐stretched section for extra support. A final option, less commonly used, is a technique called atherectomy. This treatment cuts or grinds away the fatty deposition (atheroma) within the artery that is causing the narrowing or occlusion. </p> <p><b>Key results</b> </p> <p>In this review, we compared atherectomy with the other treatment options described above. We also looked within the two groups to assess whether using drug‐releasing balloons or stents impacted on participants' outcomes. We identified seven studies with a total of 527 participants. </p> <p>Six trials compared atherectomy against balloon angioplasty (372 participants, 427 treated lesions). We found no clear difference between the procedures when examining artery patency at six and 12 months, risk of death, initial procedure failure rates, need to re‐treat the artery, risk of forming clots (embolisation), complication rates or risk of amputation. We found that atherectomy was associated with lower rates of emergency stenting during the procedure and lower balloon inflation pressures when compared with balloon angioplasty alone. We found no difference in results depending on whether the balloons were drug‐releasing or not. </p> <p>One study compared atherectomy against balloon angioplasty and primary stenting (155 participants and 155 treated lesions). This study did not report primary patency. We found no clear difference between the treatment arms in risk of death, complication rates, cardiovascular events and the need to re‐treat the artery. This study found no initial procedure failure events, </p> <p>We did not find any studies that compared bypass surgery against atherectomy.</p> <p><b>Certainty of the evidence</b> </p> <p>Overall, our certainty in the evidence is very low, which means we do not have confidence that our results show the true effect of the treatments. We downgraded our certainty in the evidence because the studies were at high risk of bias (lack of blinding of participants or assessors, several outcomes were not reported and a number of the participants did not complete the studies); the trials were all small; and their results were inconsistent. </p> <p><b>Conclusions</b> </p> <p>In conclusion, we have found no clear difference in effect on patency, mortality or cardiovascular event rates when comparing atherectomy against balloon angioplasty with or without stenting. The limited evidence available does not support a significant advantage of atherectomy over conventional balloon angioplasty or stenting. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006680-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006680-sec-0069"></div> <h3 class="title" id="CD006680-sec-0070">Implications for practice</h3> <section id="CD006680-sec-0070"> <p>This review update shows that the evidence is very uncertain about the effect of atherectomy on patency, mortality and cardiovascular event rates compared to plain balloon angioplasty, with or without stenting. We did not detect any clear differences in initial technical failure rates or target vessel revascularisation rates, but there may be reduced dissection and bailout stenting after atherectomy (very low‐certainty evidence). Included studies were small, heterogenous and at high risk of bias. Larger studies powered to detect clinically meaningful, patient‐centred outcomes are required. With the exception of bailout stenting, dissection and lower inflation pressures, there was no clear difference between atherectomy and angioplasty for any outcome. There was no evidence for atherectomy versus bypass surgery. The findings of this review agree with current widespread practice and established guidelines for balloon angioplasty in the routine treatment of people with peripheral arterial disease who are amenable to standard angioplasty. </p> </section> <h3 class="title" id="CD006680-sec-0071">Implications for research</h3> <section id="CD006680-sec-0071"> <p>Current evidence in this area is still limited. Larger and better designed trials in selected subgroups of participants are needed to increase our confidence in the evidence. However, performing a larger trial of atherectomy versus balloon angioplasty with greater power to detect differences in primary patency or limb survival may be inappropriate, considering the lack of difference in this analysis, increased technical difficulty, complication rates and the existing 'gold standard' practice of angioplasty. The exception to this may be in people with Trans‐Atlantic Inter‐Society Consensus Document on Management of Peripheral Arterial Disease (TASC) C or D lesions who are not fit for bypass surgery. </p> <p>Future trials should address the following factors.</p> <p> <ul id="CD006680-list-0010"> <li> <p>Larger studies to detect smaller differences</p> </li> <li> <p>Studies examining surgery versus atherectomy, as we found no randomised controlled trials for this comparison. Participants should be stratified according to whether they suffer from intermittent claudication or critical ischaemia. </p> </li> <li> <p>More rigorous follow‐up. It is important that future studies have both longer follow‐up and blinded outcome assessment. The procedures are sometimes performed by interventional radiologists, but followed up by vascular surgeons, so this aim is achievable. </p> </li> <li> <p>Study designs should include outcomes which are more participant‐centred, for example: quality of life; pain score; and psychosocial measures. </p> </li> </ul> </p> <p>We could not include cost in this Cochrane review, but this is a significant factor when considering results from atherectomy as it is more expensive than BA angioplasty. Future research should explore this. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006680-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006680-sec-0008"></div> <div class="table" id="CD006680-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Atherectomy compared to balloon angioplasty for peripheral arterial disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Atherectomy compared to BA for PAD</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with PAD<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> atherectomy<br/><b>Comparison:</b> BA </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with BA</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with atherectomy</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Primary patency</b> </p> <p>(follow‐up: 6 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>186<br/>(3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.06 (0.94 to 1.20)</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>575 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>609 per 1000 (540 to 690)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Primary patency</b> </p> <p>(follow‐up: 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>149<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.20 (0.78 to 1.84)</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>671 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>805 per 1000 (524 to 1000)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality</b> </p> <p>(follow‐up: 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>210<br/>(3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.50<br/>(0.10 to 2.66) </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51 per 1000 (10 to 271)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Fatal and non‐fatal cardiovascular events</b> </p> <p>(follow‐up: 24 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>160<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> reported cardiac failure and acute coronary syndrome as causes of death at 24 months, but it was unclear for which participants in which arms this was accountable for. <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> declared embolic stroke and myocardial infarction to be secondary outcomes, but no events were recorded in either arm </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>TVR</b> </p> <p>(follow‐up: 6 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>136<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.51<br/>(0.06 to 4.42) </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36 per 1000 (4 to 311)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>TVR</b> </p> <p>(follow‐up: 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>176<br/>(3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.59<br/>(0.25 to 1.42) </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>140 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82 per 1000 (35 to 198)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Complication rates</b> </p> <p>(follow‐up: 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>387<br/>(6 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.69</p> <p>(0.28 to 1.68)</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>219 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151 per 1000 (61 to 367)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>BA</b> : balloon angioplasty; <b>CI:</b> confidence interval; <b>PAD</b> : peripheral arterial disease; <b>RR:</b> risk ratio; <b>TVR</b>: target vessel revascularisation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup> We downgraded by three steps due to risk of bias (lack of blinding and high rates of attrition); imprecision (small trials with few participants and events); and inconsistency (heterogeneity). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006680-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Atherectomy compared to balloon angioplasty with primary stenting for peripheral arterial disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Atherectomy compared to BA and primary stenting for PAD</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with PAD<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> atherectomy<br/><b>Comparison:</b> BA with primary stenting </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with BA with primary stenting</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with atherectomy</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Primary patency</b> </p> <p>(follow‐up 6 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Primary patency</b> </p> <p>(follow‐up 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality</b> </p> <p>(follow‐up: 24 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>155<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.38<br/>(0.04 to 3.23) </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 per 1000 (2 to 129)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Fatal and non‐fatal cardiovascular events</b> </p> <p>(follow‐up: 24 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>155<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.38 (0.04, 3.23)</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> reported 4 deaths at 24 months (3 deaths in the drug‐eluting balloon and stent arm and 1 death in the plain balloon and stent arm) which they attributed to underlying cardiovascular disease, but no specific causes were stated. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>TVR</b> </p> <p>(follow‐up: 6 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>155<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.27<br/>(0.95 to 5.46) </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>182 per 1000 (76 to 437)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>TVR</b> </p> <p>(follow‐up: 24 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>155<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.05<br/>(0.96 to 4.37) </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>240 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>492 per 1000 (230 to 1000)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Complication rates</b> </p> <p>(follow‐up: 24 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>155<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 7.04<br/>(0.80 to 62.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> reported 3 complications, all 3 of which were in the atherectomy arm: 2 vessel perforations and 1 flow‐limiting dissection. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>BA</b> : balloon angioplasty <b>CI:</b> confidence interval; <b>PAD</b> : peripheral arterial disease; <b>RR</b> : risk ratio; <b>TVR</b>: target vessel revascularisation </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup> We downgraded by three steps due to risk of bias (inadequate blinding and high rates of attrition); and imprecision (small trial size, few participants and events, and wide confidence intervals). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006680-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006680-sec-0009"></div> <section id="CD006680-sec-0010"> <h3 class="title" id="CD006680-sec-0010">Description of the condition</h3> <p>Symptomatic peripheral arterial disease (PAD) may be treated by a number of options, including exercise therapy, angioplasty, stenting and bypass surgery (<a href="./references#CD006680-bbs2-0035" title="FowkesG , GillespieIN . Angioplasty (versus non surgical management) for intermittent claudication. Cochrane Database of Systematic Reviews1998, Issue 2. Art. No: CD000017. [DOI: 10.1002/14651858.CD000017]">Fowkes 1998</a>; <a href="./references#CD006680-bbs2-0036" title="FowkesF , LengGC . Bypass surgery for chronic lower limb ischaemia. Cochrane Database of Systematic Reviews2008, Issue 2. Art. No: CD002000. [DOI: 10.1002/14651858.CD002000.pub2]">Fowkes 2008</a>; <a href="./references#CD006680-bbs2-0065" title="WatsonL , EllisB , LengGC . Exercise for intermittent claudication. Cochrane Database of Systematic Reviews2008, Issue 4. Art. No: CD000990. [DOI: 10.1002/14651858.CD000990.pub2]">Watson 2008</a>). Atherectomy is a competing technique that uses a rotating cutting blade to excise the atheroma (<a href="./references#CD006680-bbs2-0039" title="GarciaLA , LydenSP . Atherectomy for infrainguinal peripheral artery disease. Journal of Endovascular Therapy2009;16(2 Suppl 2):II105-15.">Garcia 2009</a>). Due to the risk of vessel perforation, atherectomy tends to be performed only in the superficial femoral and popliteal arteries, though it may be used in infrapopliteal vessels. While established treatments have a strong evidence base and guidelines for their use (<a href="./references#CD006680-bbs2-0064" title="NorgrenL , HiattWR , DormandyJA , NehlerMR , HarrisKA , FowkesFG , et al, on behalf of the TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. International Angiology2007;26(2):81-157.">TASC II 2007</a>), the outcomes for atherectomy are less well understood. The National Institute for Health and Care Excellence (NICE) in the UK published guidelines in 2011, stating that there was inadequate evidence, especially given the risk of embolisation, and therefore they would not support the use of atherectomy outside of clinical trials (<a href="./references#CD006680-bbs2-0052" title="National Institute for Health and Care Excellence. Percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices [IPG380]. Available at: www.nice.org.uk/guidance/IPG3802011.">NICE 2011</a>). This guideline is still in place. </p> </section> <section id="CD006680-sec-0011"> <h3 class="title" id="CD006680-sec-0011">Description of the intervention</h3> <p>Atherectomy is an endovascular procedure for revascularisation. Pieces of atherosclerotic plaque are removed in order to increase the luminal diameter of the vessel (<a href="./references#CD006680-bbs2-0059" title="SchwarzwälderU , ZellerT . Debulking procedures: potential device specific indications. Techniques in Vascular Interventional Radiology2010;13(1):43-53.">Schwarzwälder 2010</a>). The procedure is normally performed percutaneously through a 7‐French (F) or 8‐F sheath, unless vessel access is difficult, in which case an arterial cut‐down is required. The mechanism used to remove pieces of plaque can involve a variety of techniques, but usually involves some kind of rotating cutting blade, often with a chamber to store the cut pieces. </p> </section> <section id="CD006680-sec-0012"> <h3 class="title" id="CD006680-sec-0012">Why it is important to do this review</h3> <p>This is an update of a Cochrane Review first published in 2014, which included four trials with small numbers of participants (<a href="./references#CD006680-bbs2-0066" title="AmblerGK , RadwanR , HayesPD , TwineCP . Atherectomy for peripheral arterial disease. Cochrane Database of Systematic Reviews2014, Issue 3. Art. No: CD006680. [DOI: 10.1002/14651858.CD006680.pub2]">Ambler 2014</a>). The low number of included studies and participants made it difficult for the review authors to draw conclusions. This update is important to ensure that all current evidence from randomised trials that compare atherectomy with any established treatment for PAD is identified, in order to aid decision making. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006680-sec-0013" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006680-sec-0013"></div> <p>To evaluate the effectiveness of atherectomy for peripheral arterial disease compared to other established treatments. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006680-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006680-sec-0014"></div> <section id="CD006680-sec-0015"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006680-sec-0016"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) that compared atherectomy with other established treatments, including angioplasty, stenting and bypass surgery. </p> </section> <section id="CD006680-sec-0017"> <h4 class="title">Types of participants</h4> <p>We included participants with symptomatic peripheral arterial disease (PAD) with either claudication or critical limb ischaemia and evidence of lower limb arterial disease. We considered arterial disease in any peripheral territory. We excluded studies with participants who had previously had bypass, percutaneous transluminal angioplasty (PTA) or stents in the target lesion, as these treatments might affect the primary patency rates. </p> </section> <section id="CD006680-sec-0018"> <h4 class="title">Types of interventions</h4> <p>We included RCTs that compared atherectomy against any established treatment for PAD, in order to evaluate the effectiveness of atherectomy. We identified the following comparisons for the inclusion criteria: </p> <p> <ul id="CD006680-list-0001"> <li> <p>atherectomy versus balloon angioplasty, with or without stenting;</p> </li> <li> <p>atherectomy plus adjunctive balloon angioplasty versus balloon angioplasty; and</p> </li> <li> <p>atherectomy versus surgical bypass procedures.</p> </li> </ul> </p> </section> <section id="CD006680-sec-0019"> <h4 class="title">Types of outcome measures</h4> <section id="CD006680-sec-0020"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD006680-list-0002"> <li> <p>Primary vessel patency, as assessed by ankle brachial index (ABI), arterial doppler ultrasound or angiography at six months and one year, and as data available in the studies </p> </li> <li> <p>All‐cause mortality at six months and one year, and as data available in the studies</p> </li> <li> <p>Fatal and non‐fatal cardiovascular events at six months and one year, and as data available in the studies </p> </li> </ul> </p> </section> <section id="CD006680-sec-0021"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD006680-list-0003"> <li> <p>Immediate procedural and angiographic outcomes (technical failure rates)</p> </li> <li> <p>Target vessel revascularisation rates (TVR)</p> </li> <li> <p>Complication rates, including thrombus, embolus, perforation and aneurysm</p> </li> <li> <p>Morbidity assessment, including:</p> <ul id="CD006680-list-0004"> <li> <p>tissue healing;</p> </li> <li> <p>avoidance of any amputation; and</p> </li> <li> <p>performance of less extensive amputation</p> </li> </ul> </li> <li> <p>Quality of life (QoL) outcomes, as measured in the included studies</p> </li> <li> <p>Clinical and symptomatic outcomes, e.g. improved walking distance, symptom relief</p> </li> </ul> </p> </section> </section> </section> <section id="CD006680-sec-0022"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD006680-sec-0023"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Vascular Information Specialist conducted systematic searches of the following databases for randomised controlled trials and controlled clinical trials without language, publication year or publication status restrictions: </p> <p> <ul id="CD006680-list-0005"> <li> <p>Cochrane Vascular Specialised Register via the Cochrane Register of Studies (CRS‐Web) (searched on 12 August 2019); </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 8) via the Cochrane Register of Studies Online (CRSO) </p> </li> <li> <p>MEDLINE (Ovid MEDLINE Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE Daily and Ovid MEDLINE) 1946 to Present (searched from 1 January 2017 to 12 August 2019); </p> </li> <li> <p>Embase Ovid (searched from 1 January 2017 to 12 August 2019);</p> </li> <li> <p>CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature; searched from 1 January 2017 to 12 August 2019); </p> </li> <li> <p>AMED Ovid (Allied and Complementary Medicine Database; searched from 1 January 2017 to 12 August 2019). </p> </li> </ul> </p> <p>The Information Specialist modelled search strategies for other databases on the search strategy designed for MEDLINE or CENTRAL. Where appropriate, the Information Specialist combined these with adaptations of the highly sensitive search strategy designed by the Cochrane Collaboration for identifying randomised controlled trials and controlled clinical trials (as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> Chapter 6, <a href="./references#CD006680-bbs2-0049" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from handbook.cochrane.org.">Lefebvre 2011</a>). Search strategies for major databases are provided in <a href="./appendices#CD006680-sec-0075">Appendix 1</a>. </p> <p>The Information Specialist searched the following trials registries on 12 August 2019:</p> <p> <ul id="CD006680-list-0006"> <li> <p>the World Health Organization International Clinical Trials Registry Platform (<a href="http://who.int/trialsearch" target="_blank">who.int/trialsearch</a>); </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>). </p> </li> </ul> </p> </section> <section id="CD006680-sec-0024"> <h4 class="title">Searching other resources</h4> <p>We did not search any other resources.</p> </section> </section> <section id="CD006680-sec-0025"> <h3 class="title" id="CD006680-sec-0025">Data collection and analysis</h3> <section id="CD006680-sec-0026"> <h4 class="title">Selection of studies</h4> <p>Two review authors (BW and GA) independently selected trials for inclusion in the review. They resolved any disagreements through discussion. The section '<a href="#CD006680-sec-0015">Criteria for considering studies for this review</a>' details the inclusion criteria used for the selection process. </p> </section> <section id="CD006680-sec-0027"> <h4 class="title">Data extraction and management</h4> <p>BW extracted the data, and GA cross‐checked them. They resolved any disagreements through discussion. BW extracted the following information for each trial. </p> <p> <ul id="CD006680-list-0007"> <li> <p>Trial methods: method of randomisation, method of allocation</p> </li> <li> <p>Participants: country of origin, age, sex distribution, severity of disease, as measured by the ABI and using the European Consensus definition of critical ischaemia (<a href="./references#CD006680-bbs2-0034" title="European Consensus. European consensus on critical limb ischaemia. Lancet1989;333(8640):737-8.">European Consensus Document 1989</a>), inclusion and exclusion criteria </p> </li> <li> <p>Interventions: type of procedure (atherectomy, angioplasty or bypass)</p> </li> <li> <p>Outcomes: primary and secondary outcomes, as listed in ''<a href="#CD006680-sec-0019">Types of outcome measures</a>' </p> </li> </ul> </p> <p>We extracted data directly from the published papers using data extraction forms, and did not make any attempt to obtain additional unpublished data. We based all analyses on endpoint data from the individual clinical trials, which all provided intention‐to‐treat results. We synthesised the data by comparing group results and did not amalgamate individual participant data from different trials. </p> </section> <section id="CD006680-sec-0028"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (BW, GA) assessed the included studies' risk of bias independently, using Cochrane's 'Risk of bias' tool, according to the guidelines given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> Version 5.1 (<a href="./references#CD006680-bbs2-0042" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). </p> <p>The review authors assessed the following domains as 'low risk of bias', 'unclear risk of bias' or 'high risk of bias': </p> <p> <ul id="CD006680-list-0008"> <li> <p>sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding of personnel and participants;</p> </li> <li> <p>blinding of outcome assessors;</p> </li> <li> <p>incomplete outcome data;</p> </li> <li> <p>selective outcome reporting; and</p> </li> <li> <p>other risk of bias.</p> </li> </ul> </p> <p>The <a href="./references#CD006680-sec-0085" title="">Characteristics of included studies</a> table reports the assessments for each individual study. </p> </section> <section id="CD006680-sec-0029"> <h4 class="title">Measures of treatment effect</h4> <p>We measured the treatment effects for dichotomous outcomes using risk ratios (RR) with 95% confidence intervals (CI). For continuous outcomes, we measured treatment effects as the mean difference (MD) with 95% CI. </p> </section> <section id="CD006680-sec-0030"> <h4 class="title">Unit of analysis issues</h4> <p>For the outcomes of mortality, fatal and non‐fatal cardiovascular events, complications, quality of life, and clinical and symptomatic outcomes, the unit of analysis was the individual participant rather than the treated vessel. Three trials included multiple treated vessels per participant in some cases (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>). This means that the observations from these trials will not be totally independent, and therefore should have less emphasis placed on them in the meta‐analysis. However, as the majority of participants in these trials had only one treated vessel, and very few (16%) had more than one treated vessel, it is not likely that this will have a large impact on the results presented below. We therefore did not feel it was necessary to introduce more sophisticated statistical methods such as meta‐regression to take account of these differences. We could not re‐examine the data at an individual participant level. </p> </section> <section id="CD006680-sec-0031"> <h4 class="title">Dealing with missing data</h4> <p>We performed analysis on a complete case basis, and it was not necessary to contact authors for additional data. </p> </section> <section id="CD006680-sec-0032"> <h4 class="title">Assessment of heterogeneity</h4> <p>We looked for clinical heterogeneity by examination of the study details, and used Chi<sup>2</sup> tests to assess heterogeneity between trials, using P values less than 0.1 to indicate the possible presence of significant heterogeneity. Since trials contained low participant numbers, the power of this test is likely to be low if a small P value is used (<a href="./references#CD006680-bbs2-0042" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). </p> </section> <section id="CD006680-sec-0033"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to assess the likelihood of potential publication bias using funnel plots, but we identified insufficient studies to create a funnel plot (<a href="./references#CD006680-bbs2-0042" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). </p> </section> <section id="CD006680-sec-0034"> <h4 class="title">Data synthesis</h4> <p>We intended to pool data from all studies when the clinical procedures followed were comparable. Where possible, we used inverse‐variance random‐effects models for data synthesis because the included studies used different devices for atherectomy (clinical heterogeneity) (<a href="./references#CD006680-bbs2-0032" title="DerSimonianR , LairdN . Meta-analysis in clinical trials. Controlled Clinical Trials1986;7(3):177-88.">DerSimonian 1986</a>). We used Review Manager 5.3 software to synthesise the data (<a href="./references#CD006680-bbs2-0055" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>). </p> </section> <section id="CD006680-sec-0035"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We had planned to carry out subgroup analyses where the studies reported the presence or absence of concomitant illness such as diabetes, hypertension, hyperlipidaemia, or chronic kidney disease. We had also planned to conduct subgroup analyses if the studies reported data on smoking, gender of participants, lesion location, length and percentage of stenosis, including whether any studies classified lesion length and percentage of stenosis according to the Trans‐Atlantic Inter‐Society Consensus Document on Management of Peripheral Arterial Disease (TASC II) (<a href="./references#CD006680-bbs2-0064" title="NorgrenL , HiattWR , DormandyJA , NehlerMR , HarrisKA , FowkesFG , et al, on behalf of the TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. International Angiology2007;26(2):81-157.">TASC II 2007</a>). However, the included studies did not report data on these subgroups. </p> <p>We performed subgroup analysis to investigate the differences between:</p> <p> <ul id="CD006680-list-0009"> <li> <p>atherectomy versus plain balloon angioplasty or drug‐eluting angioplasty;</p> </li> <li> <p>atherectomy versus drug‐eluting stent plus angioplasty or plain stenting plus angioplasty.</p> </li> </ul> </p> <p>We performed this subgroup analysis given the recent concerns regarding paclitaxel‐eluting devices and their potential correlation with increased risk of mortality, which arose from a systematic review and meta‐analysis by <a href="./references#CD006680-bbs2-0044" title="KatsanosK , SpiliopoulosS , KitrouP , KrokidisM , KarnabatidisD . Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. Journal of American Heart Association2018;7(24):e011245.">Katsanos 2018</a>. There was significant heterogeneity between the subgroups for plain balloon angioplasty/stenting versus drug‐eluting balloon angioplasty/stenting in both groups, so we used random‐effect models to calculate the risk ratios. </p> </section> <section id="CD006680-sec-0036"> <h4 class="title">Sensitivity analysis</h4> <p>Many participants in the atherectomy arm of the included studies underwent additional angioplasty. Not all studies specified details of this exactly, so we were unable to analyse these participants separately. The result of atherectomy is still considered successful even with additional angioplasty, so we included these participants in the atherectomy arm for analysis. Only one trial did not perform routine angioplasty with atherectomy (<a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a>). We performed sensitivity analysis to assess the effect of including this study in the overall meta‐analyses of the primary outcomes. </p> </section> <section id="CD006680-sec-0037"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We included 'Summary of findings' tables in this update to present the most important findings and the certainty of the evidence for the most clinically relevant outcomes. The seven outcomes in the 'Summary of findings' tables are: primary patency (six and 12 months); mortality; fatal and non‐fatal cardiovascular events; TVR (six and 12 months); and complications. </p> <p>We included one 'Summary of findings' table for the comparison 'Atherectomy compared to balloon angioplasty for peripheral arterial disease' (<a href="./full#CD006680-tbl-0001">summary of findings Table 1</a>) and one for 'Atherectomy compared to balloon angioplasty with primary stenting for peripheral arterial disease' (<a href="./full#CD006680-tbl-0002">summary of findings Table 2</a>). We determined the certainty of the evidence for each outcome using the GRADE approach, which considers the overall risk of bias of the included studies, the directness of the evidence, inconsistency within the results, precision of the estimate and risk of publication bias (<a href="./references#CD006680-bbs2-0040" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck-YtterY , SchunemannHJ . What is "quality of evidence" and why is it important to clinicians?BMJ2008;336:995-8.'>Guyatt 2008</a>). We created the 'Summary of findings' tables using <a href="https://archie.cochrane.org/sections/documents/view?document=265400030712001076&amp;format=REVMAN#REF-GRADEpro-GDT-2015" target="_blank">GRADEpro GDT 2015</a> software. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006680-sec-0038" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006680-sec-0038"></div> <section id="CD006680-sec-0039"> <h3 class="title">Description of studies</h3> <section id="CD006680-sec-0040"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD006680-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD006680-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD006680-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD006680-sec-0041"> <h4 class="title">Included studies</h4> <p>The '<a href="./references#CD006680-sec-0085" title="">Characteristics of included studies</a>' table summarises the details of the included studies. </p> <p>We identified three new studies for this update (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>). Overall, seven studies involving 527 participants and 581 treated lesions met the selection criteria (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a>; <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>; <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>). Six studies compared atherectomy to balloon angioplasty (BA) (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>; <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>), and one study compared atherectomy to BA and primary stenting (<a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>). None of the studies used atherectomy followed by stenting as a primary intervention; they only used bailout stenting. </p> <p>Four of the six BA studies reported on primary patency (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a>; <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>). <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a> reported follow‐up at three‐month intervals for two years. The study defined loss of patency as increased flow velocities (peak systolic velocity ratio (PSVR) ≥ 2.5) or absence of flow in occluded arterial segments on duplex ultrasound scan. <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a> reported patencies at six months' follow‐up only, and assessed patency via arterial duplex. <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> reported follow‐up patencies at six months and 12 months using duplex ultrasound (defined as PSVR ≤ 2.4). <a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a> reported clinical follow‐up along with ABIs and Rutherford classifications at 30 days, six months and 12 months. This trial also reported duplex ultrasound at six and 12 months, with primary patency defined as freedom from target lesion revascularisation or restenosis (PSV ≥ 2.5). <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>, the primary stenting trial, did not report primary patency as one of their outcomes. Instead, the study reported target vessel revascularisation data. <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> reported follow‐up target lesion revascularisation and target vessel revascularisation at 12 months. <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a> reported follow‐up target lesion revascularisation/target vessel revascularisation at three, six and 12 months. </p> <p>There were also differences in modality of follow‐up between studies: <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> used angiogram, <a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a> and <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a> used duplex ultrasound, <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> used duplex ultrasound at six months and plain ultrasound at 12 months, and <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a> used doppler pressures. Neither <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> nor <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a> used imaging at follow‐up, instead using ABI and clinical correlation. </p> <p>Overall, there were a lot of differences in the clinical design and atherectomy devices used in each study. </p> <p><a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a> compared balloon angioplasty to transluminal extraction catheter (TEC) atherectomy (<a href="./references#CD006680-bbs2-0062" title="StackRS , CaliffRM , PhillipsHR , PryorDB , QuigleyPJ , BaumanRP , et al. Interventional Cardiac Catheterization at Duke Medical Center. American Journal of Cardiology1988;62(10 Pt2):3F-24F.">Stack 1988</a>), followed by adjunctive balloon angioplasty in 39 participants with intermittent claudication (IC). TEC atherectomy utilises an over‐the‐wire device with a conical motorised cutting head with triangular blades, which rotate at 700 rpm, with a proximal suction apparatus that removes excised plaque. The study did not specify a medication protocol. </p> <p><a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a> compared balloon angioplasty to Simpson atherectomy (<a href="./references#CD006680-bbs2-0060" title="SimpsonJB , SelmonMR , RobertsonGC , CiprianoPR , HaydenWG , JohnsonDE , et al. Transluminal atherectomy for occlusive peripheral vascular disease. American Journal of Cardiology1988;16(14):96G-101G.">Simpson 1988</a>), in 73 participants with IC. The Simpson atherectomy device consists of cylindrical housing with a longitudinal opening down one side and a balloon on the other side. The balloon is inflated in order to both fix the device in place and press the longitudinal opening up against the wall of the vessel. A rotating cutting blade (2000 rpm) is then advanced through the cylinder so that any part of the vessel wall projecting through the longitudinal window will be cut away. The day before the procedure, all participants commenced low‐dose aspirin therapy. </p> <p><a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> compared balloon angioplasty to Silverhawk atherectomy followed by adjunctive balloon angioplasty in 58 participants with claudication, rest pain or minor tissue loss. The Silverhawk atherectomy device is similar to the Simpson device, described above, except the cylindrical housing is hinged in the region of the window, with the device flexing away from the window causing the tip and tail of the device to press up against one side of the vessel wall while the window is pressed up against the other side. In this trial, a distal embolism filter was used in approximately half of the participants. If participants were not already established on dual antiplatelet therapy (aspirin and clopidogrel), they were given loading doses of aspirin and clopidogrel immediately prior to the procedure. Participants on established therapy continued on their regular doses. </p> <p>Both <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a> and <a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a> compared balloon angioplasty to Diamondback atherectomy (<a href="./references#CD006680-bbs2-0041" title="HeuserRR . Treatment of lower extremity vascular disease: the Diamondback 360 degrees Orbital Atherectomy System. Expert Review of Medical Devices2008;5(3):279-86.">Heuser 2008</a>), followed by adjunctive balloon angioplasty. The Diamondback atherectomy device files away plaque, as opposed to cutting it away, via an eccentrically mounted abrasive crown on a catheter that rotates at high speed (100,000 rpm). This results in extremely small pieces of plaque, so no system for removing resulting debris is required. The <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a> trial included 50 participants with rest pain or tissue loss and stenosed, calcified vessels. The trial did not specify a medication protocol. The <a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a> trial included 50 participants (with 65 lesions) with symptomatic femoropopliteal (FP) disease. The participants had to have Rutherford class 2 to 4 symptoms (moderate claudication/Ischaemic rest pain), and de novo FP stenosis &gt; 70% with fluoroscopically visible calcium. Participants were recommended to be on an antiplatelet agent preprocedure (preferably clopidogrel), and then aspirin and clopidogrel for a minimum of four to six weeks postprocedure. </p> <p><a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> compared paclitaxel‐eluting balloon angioplasty and SilverHawk (described above) or TurboHawk atherectomy devices. The TurboHawk device is a cutting or grinding rotational atherectomy device, with the different attachments to be chosen depending upon how calcified the lesions are. It is recommended to be used in conjunction with the SpiderFX embolic protection device if using the larger cutter. This study included 102 participants with claudication or rest pain with a target lesion of ≥ 70% stenosis in the superficial femoral or popliteal artery. A uniform antiplatelet protocol was in place for both arms, requiring dual antiplatelets preprocedure, clopidogrel for four weeks postprocedure, and aspirin indefinitely. </p> <p><a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> compared paclitaxel‐eluting balloon angioplasty and stenting, balloon angioplasty and stenting, and SilverHawk atherectomy (described above) with distal protection (spider filter) and bailout stenting. The SpiderFX embolic protection device captures debris from the atherectomy procedure using a braided nitinol basket, and is placed downstream to stop distal trashing or embolisation. This study included 155 participants with symptomatic peripheral vascular disease and angiographic de novo stenosis &gt; 70% or occlusion of the superficial femoral artery. Participants were given 500 mg aspirin intravenously immediately after the procedure, then 100 mg aspirin once daily indefinitely, with 75 mg clopidogrel once daily for six months or more. </p> </section> <section id="CD006680-sec-0042"> <h4 class="title">Excluded studies</h4> <p>See <a href="./references#CD006680-sec-0086" title="">Characteristics of excluded studies</a>. </p> <p>We excluded six studies following the most recent search (<a href="./references#CD006680-bbs2-0009" title="Del GiudiceC . Synergistic strategy of laser atherectomy and drug-eluting balloon angioplasty for treatment of in-stent restenosis in the superficial femoral artery: a randomised study. In: EuroPCR Abstracts and Posters. 2014. [DOI: 10.1007/978-1-4471-5220-0_14]">Del Giudice 2014</a>; <a href="./references#CD006680-bbs2-0010" title="DippelEJ , MakamP , KovachR , GeorgeJC , PatlolaR , MetzgerDC , et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: Initial results from the EXCITE ISR Trial (EXCImer laser randomized controlled study for treatment of FemoropopliTEal in-stent restenosis). JACC: Cardiovascular Interventions2015;8(1):95-101. DippelEJ , MakamP , KovachRC , GeorgeJC , PatlolaRR , MetzgerDC , et al. Excite ISR: a prospective, randomized controlled trial of excimer laser atherectomy vs balloon angioplasty for the treatment of femoropopliteal in-stent restenosis. Journal of the American College of Cardiology2014;64(11 suppl 1):B155. ">Dippel 2015</a>; <a href="./references#CD006680-bbs2-0012" title="GandiniR , Del GiudiceC , MerollaS , MorosettiD , PampanaE , SimonettiG . Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. Journal of Endovascular Therapy2013;20:805-14. ">Gandini 2013</a>; <a href="./references#CD006680-bbs2-0014" title="NCT02730234. JetStream atherectomy for the treatment of in-stent restenosis (JET-ISR). clinicaltrials.gov/show/NCT02730234 (first received 6 April 2016). ">NCT02730234</a>; <a href="./references#CD006680-bbs2-0015" title="NCT02832024. Clinical study of stent versus direct atherectomy versus angioplasty to treat lower limb in-stent restenosis. clinicaltrials.gov/ct2/show/NCT02832024 (first received 13 July 2016). ">NCT02832024</a>; <a href="./references#CD006680-bbs2-0016" title="SchwindtAG , Bennett JG Jr, CrowderWH , DohadS , JanzerSF , GeorgeJC , et al. Lower extremity revascularization using optical coherence tomography-guided directional atherectomy: final results of the evaluatIon of the pantheris optIcal coherence tomography imaging atherectomy system for use in the peripheral vasculature (VISION) Study. Journal of Endovascular Therapy2017;24(3):355-66. ">Schwindt 2017</a>), bringing the total number of excluded studies to nine (<a href="./references#CD006680-bbs2-0008" title="BrodmannM , RiefP , FroehlichH , DorrA , GaryT , EllerP , et al. Neointimal hyperplasia after Silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial. Cardiovascular and Interventional Radiology2013;36(1):69-74. ">Brodmann 2013</a>; <a href="./references#CD006680-bbs2-0009" title="Del GiudiceC . Synergistic strategy of laser atherectomy and drug-eluting balloon angioplasty for treatment of in-stent restenosis in the superficial femoral artery: a randomised study. In: EuroPCR Abstracts and Posters. 2014. [DOI: 10.1007/978-1-4471-5220-0_14]">Del Giudice 2014</a>; <a href="./references#CD006680-bbs2-0010" title="DippelEJ , MakamP , KovachR , GeorgeJC , PatlolaR , MetzgerDC , et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: Initial results from the EXCITE ISR Trial (EXCImer laser randomized controlled study for treatment of FemoropopliTEal in-stent restenosis). JACC: Cardiovascular Interventions2015;8(1):95-101. DippelEJ , MakamP , KovachRC , GeorgeJC , PatlolaRR , MetzgerDC , et al. Excite ISR: a prospective, randomized controlled trial of excimer laser atherectomy vs balloon angioplasty for the treatment of femoropopliteal in-stent restenosis. Journal of the American College of Cardiology2014;64(11 suppl 1):B155. ">Dippel 2015</a>; <a href="./references#CD006680-bbs2-0011" title="GabrielliR , RosatiMS , VitaleS , BaciarelloG , SianiA , et al. Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions. Journal of Vascular Surgery2012;56(6):1598-605. ">Gabrielli 2012</a>; <a href="./references#CD006680-bbs2-0012" title="GandiniR , Del GiudiceC , MerollaS , MorosettiD , PampanaE , SimonettiG . Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. Journal of Endovascular Therapy2013;20:805-14. ">Gandini 2013</a>; <a href="./references#CD006680-bbs2-0013" title="GisbertzSS , RamzanM , Tutein NoltheniusRP , van derLaanL , OvertoomTT , MollFL , et al. Short-term results of a randomized trial comparing remote endarterectomy and supragenicular bypass surgery for long occlusions of the superficial femoral artery (the REVAS Trial). European Journal of Vascular and Endovascular Surgery2009;37(1):68-76. GisbertzSS , Tutein NoltheniusRP , deBorstGJ , van derLaanL , OvertoomTT , MollFL , et al. Remote endarterectomy versus supragenicular bypass surgery for long occlusions of the superficial femoral artery: medium-term results of a randomized controlled trial (the REVAS trial). Annals of Vascular Surgery2010;24(8):1015-23. ">Gisbertz 2009</a>; <a href="./references#CD006680-bbs2-0014" title="NCT02730234. JetStream atherectomy for the treatment of in-stent restenosis (JET-ISR). clinicaltrials.gov/show/NCT02730234 (first received 6 April 2016). ">NCT02730234</a>; <a href="./references#CD006680-bbs2-0015" title="NCT02832024. Clinical study of stent versus direct atherectomy versus angioplasty to treat lower limb in-stent restenosis. clinicaltrials.gov/ct2/show/NCT02832024 (first received 13 July 2016). ">NCT02832024</a>; <a href="./references#CD006680-bbs2-0016" title="SchwindtAG , Bennett JG Jr, CrowderWH , DohadS , JanzerSF , GeorgeJC , et al. Lower extremity revascularization using optical coherence tomography-guided directional atherectomy: final results of the evaluatIon of the pantheris optIcal coherence tomography imaging atherectomy system for use in the peripheral vasculature (VISION) Study. Journal of Endovascular Therapy2017;24(3):355-66. ">Schwindt 2017</a>). <a href="./references#CD006680-bbs2-0011" title="GabrielliR , RosatiMS , VitaleS , BaciarelloG , SianiA , et al. Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions. Journal of Vascular Surgery2012;56(6):1598-605. ">Gabrielli 2012</a> and <a href="./references#CD006680-bbs2-0013" title="GisbertzSS , RamzanM , Tutein NoltheniusRP , van derLaanL , OvertoomTT , MollFL , et al. Short-term results of a randomized trial comparing remote endarterectomy and supragenicular bypass surgery for long occlusions of the superficial femoral artery (the REVAS Trial). European Journal of Vascular and Endovascular Surgery2009;37(1):68-76. GisbertzSS , Tutein NoltheniusRP , deBorstGJ , van derLaanL , OvertoomTT , MollFL , et al. Remote endarterectomy versus supragenicular bypass surgery for long occlusions of the superficial femoral artery: medium-term results of a randomized controlled trial (the REVAS trial). Annals of Vascular Surgery2010;24(8):1015-23. ">Gisbertz 2009</a> performed remote endarterectomy rather than atherectomy. <a href="./references#CD006680-bbs2-0008" title="BrodmannM , RiefP , FroehlichH , DorrA , GaryT , EllerP , et al. Neointimal hyperplasia after Silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial. Cardiovascular and Interventional Radiology2013;36(1):69-74. ">Brodmann 2013</a>, <a href="./references#CD006680-bbs2-0009" title="Del GiudiceC . Synergistic strategy of laser atherectomy and drug-eluting balloon angioplasty for treatment of in-stent restenosis in the superficial femoral artery: a randomised study. In: EuroPCR Abstracts and Posters. 2014. [DOI: 10.1007/978-1-4471-5220-0_14]">Del Giudice 2014</a>, <a href="./references#CD006680-bbs2-0010" title="DippelEJ , MakamP , KovachR , GeorgeJC , PatlolaR , MetzgerDC , et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: Initial results from the EXCITE ISR Trial (EXCImer laser randomized controlled study for treatment of FemoropopliTEal in-stent restenosis). JACC: Cardiovascular Interventions2015;8(1):95-101. DippelEJ , MakamP , KovachRC , GeorgeJC , PatlolaRR , MetzgerDC , et al. Excite ISR: a prospective, randomized controlled trial of excimer laser atherectomy vs balloon angioplasty for the treatment of femoropopliteal in-stent restenosis. Journal of the American College of Cardiology2014;64(11 suppl 1):B155. ">Dippel 2015</a>, <a href="./references#CD006680-bbs2-0012" title="GandiniR , Del GiudiceC , MerollaS , MorosettiD , PampanaE , SimonettiG . Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. Journal of Endovascular Therapy2013;20:805-14. ">Gandini 2013</a> and <a href="./references#CD006680-bbs2-0015" title="NCT02832024. Clinical study of stent versus direct atherectomy versus angioplasty to treat lower limb in-stent restenosis. clinicaltrials.gov/ct2/show/NCT02832024 (first received 13 July 2016). ">NCT02832024</a> included participants with an in‐stent restenosis. We excluded <a href="./references#CD006680-bbs2-0014" title="NCT02730234. JetStream atherectomy for the treatment of in-stent restenosis (JET-ISR). clinicaltrials.gov/show/NCT02730234 (first received 6 April 2016). ">NCT02730234</a> and <a href="./references#CD006680-bbs2-0016" title="SchwindtAG , Bennett JG Jr, CrowderWH , DohadS , JanzerSF , GeorgeJC , et al. Lower extremity revascularization using optical coherence tomography-guided directional atherectomy: final results of the evaluatIon of the pantheris optIcal coherence tomography imaging atherectomy system for use in the peripheral vasculature (VISION) Study. Journal of Endovascular Therapy2017;24(3):355-66. ">Schwindt 2017</a> as they were non‐randomised single arm trials. We reassessed one previously excluded study as ongoing (<a href="./references#CD006680-bbs2-0019" title="NCT01579123. Laser atherectomy versus angioplasty for the treatment of critical limb ischemia. clinicaltrials.gov/ct2/show/NCT01579123 (first received 17 April 2012). ">NCT01579123</a>). </p> <section id="CD006680-sec-0043"> <h5 class="title">Ongoing studies</h5> <p>See <a href="./references#CD006680-sec-0087" title="">Characteristics of ongoing studies</a>. </p> <p>We identified 11 new studies that compared drug‐coated balloon angioplasty with atherectomy, and listed these as ongoing (<a href="./references#CD006680-bbs2-0017" title="ChiCTR-IOR-17012486x. Drug-coated balloon versus drug-coated balloon with atherectomy for the treatment of femoral-popliteal calcified occlusive disease: a randomized, controlled and prospective study. www.chictr.org.cn/showprojen.aspx?proj=21256 (first received 28 August 2017). ">ChiCTR‐IOR‐17012486</a>; <a href="./references#CD006680-bbs2-0018" title="MartinsenBJ , WeberSA , PietzschML , BehrensA , WeatherspoonM , IgyartoZ , et al. Economic study design for the optimize study on orbital atherectomy and drug-coated balloon devices for the treatment of below-the-knee peripheral arterial disease. Value in Health2015;18(7):A723. ">Martinsen 2015</a>; <a href="./references#CD006680-bbs2-0019" title="NCT01579123. Laser atherectomy versus angioplasty for the treatment of critical limb ischemia. clinicaltrials.gov/ct2/show/NCT01579123 (first received 17 April 2012). ">NCT01579123</a>; <a href="./references#CD006680-bbs2-0020" title="NCT01763476. Atherectomy and drug-coated balloon angioplasty in treatment of long infrapopliteal lesions. clinicaltrials.gov/ct2/show/NCT01763476 (first received 9 January 2013). ">NCT01763476</a>; <a href="./references#CD006680-bbs2-0021" title="NCT02514460. Clinical study of stent versus direct atherectomy to treat lower limb ischemia. clinicaltrials.gov/ct2/show/NCT02514460 (first received 3 August 2015). ">NCT02514460</a>; <a href="./references#CD006680-bbs2-0022" title="NCT02517827. Percutaneous intervention versus surgery in the treatment of common femoral artery lesions. clinicaltrials.gov/ct2/show/NCT02517827 (first received 7 August 2015). ">NCT02517827</a>; <a href="./references#CD006680-bbs2-0023" title="NCT02561299. Orbital vessel preparation to maximize dcb efficacy in calcified below the knee (BTK) lesions - a pilot study. clinicaltrials.gov/ct2/show/NCT02561299 (first received 28 September 2015). ">NCT02561299</a>; <a href="./references#CD006680-bbs2-0024" title="NCT02840786. Clinical study of stent versus direct atherectomy to treat arteriosclerosis occlusive disease of lower extremity. clinicaltrials.gov/ct2/show/NCT02840786 (first received 26 July 2016). ">NCT02840786</a>; <a href="./references#CD006680-bbs2-0025" title="NCT03206762. JET-RANGER Trial - JETStream atherectomy with adjunctive Paclitaxel-coated balloon angioplasty vs plain old balloon angioplasty followed by Paclitaxel-coated balloon. clinicaltrials.gov/ct2/show/NCT03206762 (first received 2 July 2017). ">NCT03206762</a>; <a href="./references#CD006680-bbs2-0026" title="NCT03380650. Study of DA+LDD in the treatment of femoropopliteal occlusive disease. clinicaltrials.gov/ct2/show/NCT03380650 (first received 21 December 2017). ">NCT03380650</a>; <a href="./references#CD006680-bbs2-0027" title="NCT03495453. Directional versus orbital atherectomy plaque modification and luminal area assessment of the femoro-popliteal artery via intravascular ultrasound. clinicaltrials.gov/ct2/show/NCT03495453 (first received 12 April 2018). ">NCT03495453</a>). Two studies previously assessed as ongoing are now included studies (<a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>). </p> </section> </section> </section> <section id="CD006680-sec-0044"> <h3 class="title">Risk of bias in included studies</h3> <p>The 'Risk of bias' assessments are presented in the '<a href="./references#CD006680-sec-0085" title="">Characteristics of included studies</a>' table and summarised in <a href="#CD006680-fig-0002">Figure 2</a> and <a href="#CD006680-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD006680-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006680-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD006680-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006680-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD006680-sec-0045"> <h4 class="title">Allocation</h4> <p>We judged four of the studies to be at low risk for randomisation methods: <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a> used a random numbers table; <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> used a computer‐generated sequence; <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a> used numbered envelopes opened sequentially and <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> used block randomisation by centre. Three studies were of unclear risk for randomisation methods: <a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a> did not state the method of randomisation; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> performed simple randomisation on a 1:1 basis, but did not describe the method of sequence generation; and <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a> stated that sealed envelopes were provided to all centres for randomisation, but did not report the randomisation method. </p> <p>We deemed five studies to be at low risk for allocation bias. <a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>, <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>, <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a> and <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> performed randomisation only after passing the guidewire and assessing inclusion and exclusion criteria, and used sealed envelopes to conceal allocation. <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> used sealed envelopes for allocation concealment. <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> assigned participants to treatment groups after successful passage of the guidewire across the target lesion, so we judged this to be at unclear risk. <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a> did not report any method of allocation concealment, so we judged this to be at high risk. </p> </section> <section id="CD006680-sec-0046"> <h4 class="title">Blinding</h4> <p>It is not possible to blind operators for this procedure, so we assessed all trials to be at high risk for performance bias (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a>; <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>; <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>). We also deemed bailout stenting to be at high risk of bias, given that the decision is made at the time of intervention by non‐blinded technicians, who could therefore influence results. Blinding for postprocedure follow‐up is possible, but <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> appears to have been the only study to implement this fully, as the independent core laboratory was blinded to the treatment assignment, We therefore considered <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> to be at low risk of detection bias. <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> blinded the duplex ultrasound core laboratory staff and clinical events committee, but none of the other outcome assessors, giving an unclear risk of detection bias. We judged all of the remaining studies to be at high risk of detection bias (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>; <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a>). There was, therefore, an overall risk of both performance and detection bias in all seven trials. </p> </section> <section id="CD006680-sec-0047"> <h4 class="title">Incomplete outcome data</h4> <p>Five of the seven studies had high risk of attrition bias due to significant numbers of participants not being followed up to both six and 12 months (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>; <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a>). We judged <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> to be at unclear risk of bias. Although participants in the study were lost to follow‐up, only 15/102 failed to provide primary outcome data. We deemed <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a> to be at low risk because there was a complete data set up to six months. Overall, we had serious concerns about the presence of attrition bias. </p> </section> <section id="CD006680-sec-0048"> <h4 class="title">Selective reporting</h4> <p>All studies reported the primary outcomes fully, but two studies failed to completely report all secondary outcomes. <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a> reported initial and six‐month patencies, but only reported ABIs for participants whose vessels remained patent. We therefore judged this study to be at unclear risk of selection bias. <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> also failed to completely report follow‐up ABIs and did not fully report major adverse events, so we considered this to be at high risk of selection bias. The remaining studies reported all outcomes fully, so we rated them to be at low risk of selective reporting (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>; <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>) . </p> </section> <section id="CD006680-sec-0049"> <h4 class="title">Other potential sources of bias</h4> <p>Antiplatelet protocols were clear and uniform in four studies, reducing the risk of confounding by medication differences and so were at low risk of other bias (<a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>). <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a> and <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a> did not address antiplatelet protocols, which may have impacted outcomes between participant groups. We judged these to be at high risk as no antiplatelet protocol was in place. We considered <a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a> to be 'unclear' for risk of other bias, as the trial randomised vessels rather than participants, meaning a participant could be enrolled more than once and therefore could confound results. </p> </section> </section> <section id="CD006680-sec-0050"> <h3 class="title" id="CD006680-sec-0050">Effects of interventions</h3> <p>See: <a href="./full#CD006680-tbl-0001"><b>Summary of findings 1</b> Atherectomy compared to balloon angioplasty for peripheral arterial disease</a>; <a href="./full#CD006680-tbl-0002"><b>Summary of findings 2</b> Atherectomy compared to balloon angioplasty with primary stenting for peripheral arterial disease</a> </p> <p>See <a href="./full#CD006680-tbl-0001">summary of findings Table 1</a> for the comparison 'Atherectomy compared to balloon angioplasty for peripheral arterial disease'. </p> <p>See <a href="./full#CD006680-tbl-0002">summary of findings Table 2</a> for the comparison 'Atherectomy compared to balloon angioplasty with primary stenting for peripheral arterial disease'. </p> <p>We performed meta‐analyses using a random‐effects model as there was clinical heterogeneity between the studies due to the different devices used. </p> <section id="CD006680-sec-0051"> <h4 class="title">Primary outcomes</h4> <section id="CD006680-sec-0052"> <h5 class="title">Primary vessel patency</h5> <p>Three of the six atherectomy versus BA studies reported primary patency at six months (<a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a>; <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>). Pooled analysis did not show any clear benefit of atherectomy primary patency at six months (RR 1.06, 95% CI 0.94 to 1.20; 3 studies, 186 participants; very low‐certainty evidence <a href="./references#CD006680-fig-0004" title="">Analysis 1.1</a>) or at 12 months (RR 1.20, 95% CI 0.78 to 1.84; 2 studies, 149 participants; very low‐certainty evidence; <a href="./references#CD006680-fig-0005" title="">Analysis 1.2</a>). We downgraded the certainty of the evidence from high to very low due to risk of bias (inadequate blinding and high rates of attrition); imprecision (small trial sizes); and inconsistency (from heterogeneity). </p> <p>In the atherectomy versus primary stenting study, <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> did not report primary patency. </p> </section> <section id="CD006680-sec-0053"> <h5 class="title">All‐cause mortality</h5> <p>In the atherectomy versus BA comparison, three studies reported mortality rates at one year (<a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>). In <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>, there were an unexpectedly high number of deaths in the BA arm (6/25 (24%) participants), with no deaths in the atherectomy arm, though the trialists could find no good explanation for this. <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> reported 4/29 (14%) deaths in the BA arm and 2/29 (7%) deaths in the atherectomy arm. <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> reported one‐year mortality as 2/48 (4%) deaths in the atherectomy arm compared to 1/54 (2%) deaths in the BA arm. These deaths were not attributed to the procedure, however, with the causes listed as heart failure/stroke, acute coronary syndrome, respiratory failure and neoplastic disorder. Meta‐analysis of this endpoint showed no difference in mortality between the two arms (RR 0.50, 95% CI 0.10 to 2.66; 3 studies; 210 participants; very low‐certainty evidence; <a href="./references#CD006680-fig-0006" title="">Analysis 1.3</a>). We downgraded the certainty of the evidence from high to very low due to risk of bias (inadequate blinding and high rates of attrition); imprecision (small trial sizes); and inconsistency (from heterogeneity). </p> <p>In the atherectomy versus primary stenting comparison, <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> reported mortality at six and 24 months as a secondary outcome. <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> reported one postprocedural death caused by haemorrhagic shock secondary to retroperitoneal bleeding in the stenting and drug‐eluting balloon arm. At 24 months, they reported three deaths in the drug‐eluting balloon and stent arm, one death in the plain balloon and stent arm and no deaths in the atherectomy arm. All of these deaths were attributed to underlying cardiovascular disease (RR 0.38, 95% CI 0.04 to 3.23; 1 study, 155 participants; very low‐certainty evidence; <a href="./references#CD006680-fig-0016" title="">Analysis 2.1</a>). We downgraded the certainty of the evidence from high to very low due to risk of bias (inadequate blinding and high rates of attrition) and imprecision (small trial size). </p> </section> <section id="CD006680-sec-0054"> <h5 class="title">Fatal and non‐fatal cardiovascular events</h5> <p>Three studies reported cardiovascular outcomes (<a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>). </p> <p>In the atherectomy versus BA comparison, <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> reported cardiac failure and acute coronary syndrome as causes of death at 24 months, but it was unclear which participants in which arms this related to. <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> declared embolic stroke and myocardial infarction to be secondary outcomes, but recorded no events in either arm. We downgraded the certainty of the evidence from high to very low due to risk of bias (inadequate blinding and high rates of attrition); imprecision (small trial sizes); and inconsistency (from heterogeneity). </p> <p>In the atherectomy versus primary stenting comparison, <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> reported four deaths at 24 months (three deaths in the drug‐eluting balloon and stent arm and one death in the plain balloon and stent arm). The trialists attributed these to underlying cardiovascular disease, but did not state any specific causes (RR 0.38, 95% CI 0.04 to 3.23; 1 study, 155 participants; very low‐certainty evidence; <a href="./references#CD006680-fig-0017" title="">Analysis 2.2</a>). </p> </section> </section> <section id="CD006680-sec-0055"> <h4 class="title">Secondary outcomes</h4> <section id="CD006680-sec-0056"> <h5 class="title">Immediate procedural and angiographic outcomes</h5> <p>All seven trials reported on initial technical failure rates (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a>; <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>; <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>). We were able to pool the six trials that compared atherectomy to BA. There was no clear improved technical success when using atherectomy compared to BA alone (RR 0.48, 95% CI 0.22 to 1.08; 6 studies; 425 treated vessels; very low‐certainty evidence; <a href="./references#CD006680-fig-0007" title="">Analysis 1.4</a>). In the drug‐eluting balloon angioplasty subgroup, there was an apparent benefit from atherectomy (RR 0.29, 9% CI 0.12 to 0.72, 1 study; 101 treated vessels; very low‐certainty evidence). However, the test for subgroup differences did not demonstrate a difference between the balloon angioplasty and drug‐eluting balloon angioplasty groups (P = 0.32). </p> <p>In the atherectomy versus primary stenting trial (<a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>), there were no initial technical failures in either arm (<a href="./references#CD006680-fig-0018" title="">Analysis 2.3</a>). </p> <p>We downgraded the certainty of the evidence from high to very low across both comparisons due to risk of bias (inadequate blinding and high rates of attrition); imprecision (small trial sizes); and inconsistency (from heterogeneity). </p> <p>Four studies that compared atherectomy with BA reported rates of bailout stenting, with similar indications (presence of severe dissection or &gt; 30% residual stenosis) in both arms (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>). <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a> also reported perforation or significant vessel recoil as a reason for bailout stenting. There were higher incidences of bailout stenting in the BA participants (RR 0.26, 95% CI 0.09 to 0.74; 4 studies, 315 treated vessels; very low‐certainty evidence; <a href="./references#CD006680-fig-0008" title="">Analysis 1.5</a>). We downgraded the certainty of the evidence from high to very low due to risk of bias (inadequate blinding and high rates of attrition); imprecision (small trial sizes); and inconsistency (from heterogeneity). </p> <p>The atherectomy versus primary stenting trial by <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> reported that 14/55 (25%) participants in the atherectomy group received bailout stenting due to flow‐limiting dissections, one of whom developed thrombus requiring thrombus aspiration. Two participants had perforations, one treated with a covered stent, the other by prolonged balloon inflation and protamine administration. We downgraded the certainty of the evidence from high to very low due to risk of bias (inadequate blinding and high rates of attrition); imprecision (small trial sizes); and inconsistency (from heterogeneity). </p> <p>Three studies that compared atherectomy with BA reported balloon inflation pressures (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>). Meta‐analysis showed a reduction in balloon pressures needed to inflate the angioplasty balloons (MD ‐3.68 mmHg, 95% CI ‐5.36 to ‐2.01; 3 studies, 213 treated vessels; very low‐certainty evidence; <a href="./references#CD006680-fig-0009" title="">Analysis 1.6</a>). We downgraded the certainty of the evidence from high to very low due to risk of bias (inadequate blinding and high rates of attrition); imprecision (small trial sizes); and inconsistency (from heterogeneity). The atherectomy versus primary stenting trial did not report balloon inflation pressures (<a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>). </p> </section> <section id="CD006680-sec-0057"> <h5 class="title">Target vessel revascularisation rates</h5> <p>There was some variation between trials as to whether they collected target lesion revascularisation data or target vessel revascularisation data, or both. Upon discussion, we made the decision to collect target vessel revascularisation data, as we felt this allowed us to perform the fairest comparison between all studies, as only a small minority of participants had more than one lesion treated and only <a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a> reported target lesion revascularisation rates. For this reason, we have not included <a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a> in the meta‐analysis. </p> <p>Three atherectomy versus BA studies reported TVR as one of their outcomes (<a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>). Two of the studies reported six‐month TVR. <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a> reported 0/22 (0%) in the atherectomy arm and 3/20 (15%) in the angioplasty arm; and <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> reported 2/43 (5%) in the atherectomy arm and 2/51 (4%) in the angioplasty arm. On pooling the study data, we found no clear differences between the two arms at six months (RR 0.51, 95% CI 0.06 to 4.42; 2 studies, 136 treated vessels; very low‐certainty evidence; <a href="./references#CD006680-fig-0010" title="">Analysis 1.7</a>). We downgraded the certainty of the evidence from high to very low due to risk of bias (inadequate blinding and high rates of attrition); imprecision (small trial sizes); and inconsistency (from heterogeneity). <a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a> reported that 6/35 (17%) participants in the atherectomy arm and 2/26 (8%) participants in the angioplasty arm required revascularisation by six months. </p> <p><a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>, <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a> and <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> all reported 12‐month TVR outcomes. The pooled analysis showed no clear benefit when using atherectomy (RR 0.59, 95% CI 0.25 to 1.42; 3 studies, 176 treated vessels; very low‐certainty evidence; <a href="./references#CD006680-fig-0011" title="">Analysis 1.8</a>). We downgraded the certainty of the evidence from high to very low due to risk of bias (inadequate blinding and high rates of attrition); imprecision (small trial sizes); and inconsistency (from heterogeneity). </p> <p>For the comparison of atherectomy versus primary stenting with or without drug eluting balloon, <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> reported TVR at six months and 24 months. Results did not show a clear difference between the treatment arms for either six‐month TVR (RR 2.27, 95% CI 0.95 to 5.46; 1 study, 155 participants; very low‐certainty evidence; <a href="./references#CD006680-fig-0019" title="">Analysis 2.4</a>) or 24‐month TVR (RR 2.05, 95% CI 0.96 to 4.37; 1 study, 155 participants; very low‐certainty evidence; <a href="./references#CD006680-fig-0020" title="">Analysis 2.5</a>). We downgraded the certainty of the evidence from high to very low due to risk of bias (inadequate blinding and high rates of attrition); and imprecision (small trial size and wide confidence intervals). </p> </section> <section id="CD006680-sec-0058"> <h5 class="title">Complication rates</h5> <p>All six studies in the atherectomy versus BA comparison reported complication events, with no clear difference detected (RR 0.69, 95% CI 0.28 to 1.68; 6 studies, 387 participants; very low‐certainty evidence; <a href="./references#CD006680-fig-0012" title="">Analysis 1.9</a>) (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>; <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>). Atherectomy showed no clear difference in the incidence of embolisation (RR 2.51, 95% CI 0.64 to 9.80; 6 studies, 387 participants; very low‐certainty evidence; <a href="./references#CD006680-fig-0013" title="">Analysis 1.10</a>). We detected lower incidences of dissection following atherectomy (RR 0.28, 95% CI 0.14 to 0.54; 4 studies, 290 participants; very low‐certainty evidence; <a href="./references#CD006680-fig-0014" title="">Analysis 1.11</a>). We downgraded the certainty of the evidence from high to very low due to risk of bias (inadequate blinding and high rates of attrition); imprecision (small trial sizes); and inconsistency (from heterogeneity). </p> <p><a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a> reported that 0/25 (0%) participants in the atherectomy arm and 1/25 (4%) participants in the angioplasty arm had a perforation during the procedures. Six participants in the atherectomy arm and 13 participants in the angioplasty arm had a dissection, but the trialists did not report whether any of these participants required further intervention as a result. They did not report any other complications. </p> <p><a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a> reported that 3/13 (23%) participants in the balloon angioplasty group had perforations due to guidewire manipulation, all of which were treated conservatively. In the atherectomy group, 1/26 (4%) participants had a perforation, 4/26 (15%) participants had distal embolisation and two of the atherectomy devices broke intraprocedure. They also reported that one participant had an acute myocardial infarction during the operation, but did not state which intervention arm the participant belonged to. </p> <p><a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a> reported that 1/25 (4%) participants in the atherectomy arm and 6/25 (24%) participants in the angioplasty arm experienced vessel dissection. Five of these were treated by stent placement, and two (both in the angioplasty arm) were treated with dilatation. One of the 25 participants (4%) in the atherectomy arm received a stent for slow flow, and 1/25 (4%) participants in the angioplasty arm received a stent for vessel recoil. One of the 25 participants (4%) in the angioplasty arm experienced vessel perforation (treated by balloon dilatation), and 1/25 (4%) participants in the angioplasty arm experienced distal embolisation. </p> <p><a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> reported that one of the 29 participants (3%) in the atherectomy arm, who was not treated with a distal embolisation filter, had a clinically significant distal embolisation that required mechanical and pharmacological therapy. In the atherectomy arm, 17/29 (58%) participants were treated with a distal embolisation filter, of whom 11/17 (65%) had macroembolisation with debris larger than 2 mm captured in the filter. None of the 10 participants in the angioplasty group who were treated with a filter had significant debris caught in it. No participants treated with a filter had clinically significant embolisation distal to the filter, and all filters were removed without further complications. </p> <p><a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a> reported one large dissection that caused superficial femoral occlusion after three months, and one small dissection in the atherectomy arm (38 participants). The study also reported one thrombosis event in the atherectomy arm during the procedure, which was treated with streptokinase, and one case of failure to pass the guidewire. In the balloon angioplasty arm, the trialists reported that there were five small dissections among the 35 participants. </p> <p><a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> reported that there were two clinically significant distal embolisation events that required endovascular intervention, and one distal embolisation event that was not clinically significant in the atherectomy cohort (48 participants). Additionally, two perforations occurred in this group, which were successfully treated with prolonged percutaneous transluminal angioplasty. No embolisations and no perforations occurred in the angioplasty group (54 participants). In the angioplasty arm, 10 grade C or higher dissections occurred, with only one in the atherectomy arm. </p> <p><a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> (atherectomy versus primary stenting) reported three complications, all of which were in the atherectomy arm (55 participants): two vessel perforations and one flow‐limiting dissection (<a href="./references#CD006680-fig-0021" title="">Analysis 2.6</a>). </p> </section> <section id="CD006680-sec-0059"> <h5 class="title">Morbidity assessment</h5> <p>Four studies reported rates of amputation, three of which compared atherectomy versus BA (<a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>), with only one event across all trials (in the angioplasty arm of <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>) (RR 0.33, 95% CI 0.01 to 7.80; 3 studies, 178 participants; very low‐certainty evidence; <a href="./references#CD006680-fig-0015" title="">Analysis 1.12</a>). We downgraded the certainty of the evidence from high to very low due to risk of bias (inadequate blinding and high rates of attrition); imprecision (small trial sizes); and inconsistency (from heterogeneity). </p> <p>There were no amputation events in the study that compared atherectomy versus BA and primary stenting (<a href="./references#CD006680-fig-0022" title="">Analysis 2.7</a>; <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>). </p> </section> <section id="CD006680-sec-0060"> <h5 class="title">Quality of life outcomes</h5> <p>None of the included studies reported on quality of life outcomes.</p> </section> <section id="CD006680-sec-0061"> <h5 class="title">Clinical and symptomatic outcomes</h5> <p>Two atherectomy versus BA trials reported clinical and symptomatic outcomes. <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> reported functional outcomes in their study, including pain score, walking distance score, walking speed score and stair climbing score for baseline, six months and one year. However, they did not report any benefit for any of the outcomes at either time period. None of the other studies reported clinical or symptomatic outcomes. <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> reported 30‐day and 12‐month ABI and Rutherford class, and stated that there was no difference between any of these outcomes in the two treatment arms. </p> <p>The atherectomy versus primary stenting trial did not report clinical and symptomatic outcomes (<a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>). </p> </section> </section> <section id="CD006680-sec-0062"> <h4 class="title">Sensitivity analysis</h4> <p>Three studies treated more than one vessel per participant or limb (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>). It is possible, therefore, that the outcomes of these trials received greater weight in the meta‐analysis than is appropriate in the analysis of six‐month and 12‐month patency and TVR. Ideally, we would have carried out sensitivity analysis to assess the impact this had upon the results. However, given the low number of studies, this was not possible. </p> <p>Only <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a> did not perform routine angioplasty with atherectomy. We performed sensitivity analysis to assess the effect of including this study in the overall meta‐analyses of the primary outcomes (primary vessel patency and all‐cause mortality), and did not observe any difference between including or excluding this study in the analysis. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006680-sec-0063" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006680-sec-0063"></div> <section id="CD006680-sec-0064"> <h3 class="title" id="CD006680-sec-0064">Summary of main results</h3> <p>The main findings from this update involving seven RCTs (527 participants and 581 treated lesions) show that the evidence is very uncertain about the effect of atherectomy on primary patency compared to balloon angioplasty (BA) or primary stenting at either six or 12 months (<a href="./references#CD006680-fig-0004" title="">Analysis 1.1</a>; <a href="./references#CD006680-fig-0005" title="">Analysis 1.2</a>). There was also no clear difference in mortality between atherectomy and BA or primary stenting (very low‐certainty evidence; <a href="./references#CD006680-fig-0006" title="">Analysis 1.3</a>; <a href="./references#CD006680-fig-0016" title="">Analysis 2.1</a>). Although cardiac events were reported in two of the atherectomy versus BA trials, in one study it was unclear which arm the participants belonged to and the second study reported no events. Cardiac event rates showed no clear difference between atherectomy and primary stenting (very low‐certainty evidence; <a href="./references#CD006680-fig-0017" title="">Analysis 2.2</a>). </p> <p>Initial technical failure rates showed no clear difference when using atherectomy compared with BA (very low‐certainty evidence; <a href="./references#CD006680-fig-0007" title="">Analysis 1.4</a>), and there were no events available for comparison between atherectomy and BA with primary stenting (very low‐certainty evidence; <a href="./references#CD006680-fig-0018" title="">Analysis 2.3</a>). </p> <p>There was a reduction in the need for bailout stenting associated with a reduction in the inflation pressure necessary to achieve an optimal balloon inflation in the atherectomy arm compared to BA (very low‐certainty evidence; <a href="./references#CD006680-fig-0008" title="">Analysis 1.5</a> and <a href="./references#CD006680-fig-0009" title="">Analysis 1.6</a>, respectively). </p> <p>When comparing atherectomy with BA, TVR was not reduced at either six or 12 months (very low‐certainty evidence; <a href="./references#CD006680-fig-0010" title="">Analysis 1.7</a> and <a href="./references#CD006680-fig-0011" title="">Analysis 1.8</a>). In the atherectomy versus primary stenting arms, analysis did not show any clear benefit of primary stenting on TVR at either six or 24 months (very low‐certainty evidence; <a href="./references#CD006680-fig-0019" title="">Analysis 2.4</a>; <a href="./references#CD006680-fig-0020" title="">Analysis 2.5</a>). </p> <p>This review showed there was no overall reduction in complications when using atherectomy compared with BA (very low‐certainty evidence; <a href="./references#CD006680-fig-0012" title="">Analysis 1.9</a>). The atherectomy versus BA trials reported embolisation and dissection events. Embolisation events were fewer in the BA arm, although results are subject to very low certainty; <a href="./references#CD006680-fig-0013" title="">Analysis 1.10</a>). Dissection events were fewer in the atherectomy arm (very low‐certainty evidence; <a href="./references#CD006680-fig-0014" title="">Analysis 1.11</a>). </p> <p>There was only one amputation event in the three trials (178 participants) which compared atherectomy with angioplasty (very low‐certainty evidence; <a href="./references#CD006680-fig-0015" title="">Analysis 1.12</a>), and there were no events in the atherectomy versus primary stenting trial. </p> <p><a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> was the only trial to report clinical and symptomatic outcomes, such as walking distance or symptom relief, with no reported benefit. Similarily, <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> reported no differences between groups in terms of ABI and Rutherford classification; outcomes reported only by <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>. </p> <p>We performed subgroup analysis in this review because the included trials used both drug‐eluting and plain balloon angioplasty devices as control arms. However, we found no clear difference between these two groups for any outcome in either comparison. </p> <p>One concern with atherectomy devices is the risk of distal embolisation, as the devices physically cut or grind plaques (<a href="./references#CD006680-bbs2-0030" title="BriguoriC , DiMarioC , ColomboA . Distal embolization during directional coronary atherectomy. Journal of Invasive Cardiology2003;15(8):448-50.">Briguori 2003</a>). One of the included studies found this to be a particular issue, and deployed a distal embolic filter in 17/29 (59%) of participants, which caught macroembolic debris (defined as debris greater than 2 mm in the longest axis) in 11/17 (65%) cases (<a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>). The filter was deployed in 10/29 (34%) of the participants in the BA arm, but did not catch macroemboli in any cases. In addition, one participant in the atherectomy arm who was treated without a filter had a clinically significant distal embolic event. In <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>, one participant out of 20 (5%) in the BA arm had a clinically significant embolic event. <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> reported two clinically significant distal embolic events that required endovascular intervention in the atherectomy cohort. However, the device used comes with a recommendation to use a SpiderFX embolic filter if using the larger atherectomy device. </p> </section> <section id="CD006680-sec-0065"> <h3 class="title" id="CD006680-sec-0065">Overall completeness and applicability of evidence</h3> <p>This update includes all information from RCTs identified by the searches, and we have presented an up‐to‐date meta‐analysis of atherectomy versus any other therapy for peripheral arterial disease (PAD). We found comparisons for atherectomy versus BA and atherectomy versus primary stenting plus angioplasty; but not for atherectomy versus bypass surgery. </p> <p>The indication for intervention was claudication in two studies (<a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a>; <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a>); claudication or rest pain in <a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; and claudication, rest pain or tissue loss in three studies (<a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>). Results of angioplasty and bypass surgery are known to vary between people with these indications (<a href="./references#CD006680-bbs2-0064" title="NorgrenL , HiattWR , DormandyJA , NehlerMR , HarrisKA , FowkesFG , et al, on behalf of the TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. International Angiology2007;26(2):81-157.">TASC II 2007</a>), so may bias the results from the different studies. Some of the included studies did not state the severity of claudication, which may mean that the participants would have been managed conservatively in many centres (<a href="./references#CD006680-bbs2-0037" title="FransFA , BipatS , ReekersJA , LegemateDA , KoelemayMJ . Systematic review of exercise training or percutaneous transluminal angioplasty for intermittent claudication. British Journal of Surgery2012;99(1):16-28.">Frans 2012</a>), so the results should be interpreted with a degree of caution. Unfortunately, we were not able to separate results by symptoms (claudication or critical ischaemia) because of the way the studies reported results. In addition, the majority of included studies did not report on all of this review's prespecified outcomes. Therefore, the findings of this review are based in most cases on results from only one or two studies. </p> <p>Amputation‐free survival is an important endpoint in trials for chronic limb threatening ischaemia, but the included trials did not report this. One reason may be the reliance on including participants with less severe form of peripheral arterial disease (claudication) into the trials. </p> <p>Mortality is commonly reported in trials of lower limb revascularisation, which is why we considered it a primary outcome measure. However, mortality rates from angioplasty are much lower than primary patency or limb loss rates (<a href="./references#CD006680-bbs2-0047" title="LairdJR , KatzenBT , ScheinertD , LammerJ , CarpenterJ , BuchbinderM , et al, on behalf of the RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circulation. Cardiovascular Interventions2010;3(3):267-76.">Laird 2010</a>; <a href="./references#CD006680-bbs2-0057" title="SchillingerM , SabetiS , LoeweC , DickP , AmighiJ , MlekuschW , et al. Balloon angioplasty versus implantation of Nitinol stents in the superficial femoral artery. New England Journal of Medicine2006;354(18):1879-88.">Schillinger 2006</a>), so trials would not be expected to show a difference if powered to detect primary patency. The results presented may be a consequence of random error due to few events in small sample sizes. There was little difference in all‐cause mortality rates between interventions, but mortality was only reported in four of the seven included trials, and rates of death were low (16 deaths out of 365 participants (4%)). </p> <p>In addition, there were differences in modality of follow‐up between studies, which could introduce potential bias: <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> used angiogram; <a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a> and <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a> used duplex ultrasound; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> used duplex ultrasound at six months and plain ultrasound at 12 months; and <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a> used doppler pressures. Neither <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> nor <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a> used imaging at follow‐up; instead they used ABI and clinical correlation. These differences in outcome collection should be considered when interpreting the results. </p> </section> <section id="CD006680-sec-0066"> <h3 class="title" id="CD006680-sec-0066">Quality of the evidence</h3> <p>All seven included studies were of poor methodological quality, with a high risk of overall bias due to a lack of blinding and high attrition, meaning the conclusions that can be drawn from the analyses are severely limited. There was significant statistical heterogeneity between studies, due to the small participant numbers. In addition, there was heterogeneity due to clinical differences in participant groups, trial protocols and target vessels. Only one included trial compared stenting versus atherectomy (<a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a>). We interpreted the results for any outcome with only one study with caution, given the small trial sizes and lack of information. Using the GRADE approach, which considers the overall risk of bias of the included studies, the directness of the evidence, inconsistency within the results, precision of the estimate and risk of publication bias (<a href="./references#CD006680-bbs2-0040" title='GuyattGH , OxmanAD , KunzR , VistGE , Falck-YtterY , SchunemannHJ . What is "quality of evidence" and why is it important to clinicians?BMJ2008;336:995-8.'>Guyatt 2008</a>), we judged all outcomes to have very low‐certainty evidence. <a href="./full#CD006680-tbl-0001">summary of findings Table 1</a> and <a href="./full#CD006680-tbl-0002">summary of findings Table 2</a> show that there is currently no clear evidence to support the use of atherectomy as a treatment for peripheral vascular disease. We downgraded all the outcomes from high to very low‐certainty due to risk of bias (inadequate blinding and high rates of attrition); imprecision (small trial sizes); and inconsistency (from heterogeneity). </p> <p>Only <a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> and <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> utilised power calculations to assess the required number of participants. Overall study numbers were very low, and meta‐analysis of very low participant numbers in randomised trials can be unreliable (<a href="./references#CD006680-bbs2-0054" title="RerkasemK , RothwellPM . Meta-analysis of small randomised controlled trials in surgery may be unreliable. British Journal of Surgery2010;97(4):466-9.">Rerkasem 2010</a>). As a result, the observed lack of difference in primary patency could easily be a type II error. Two of the trials did not state medication protocols (<a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>). This may be important as it is known that the use of antiplatelet agents, cilostazol, and heparin are all associated with lower restenosis rates after angioplasty (<a href="./references#CD006680-bbs2-0056" title="RobertsonL , GhouriMA , KovacsF . Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. Cochrane Database of Systematic Reviews2012, Issue 8. Art. No: CD002071. [DOI: 10.1002/14651858.CD002071.pub3]">Robertson 2012</a>). The included trials did not include important clinical endpoints such as secondary patency, limb survival, and complication rates between techniques in sufficient detail. </p> <p>One included study compared atherectomy alone with BA (<a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a>), whereas five trials compared atherectomy plus adjunctive BA with BA alone (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0002" title="NakamuraS , ConroyRM , GordonIL , DeutschLS , MaheswaranB , AntoneCS , et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. Journal of Clinical Ultrasound1995;23(8):461-71. ">Nakamura 1995</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>; <a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a>), creating concerns about heterogeneity. Three participants in the atherectomy arm of <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a> crossed over and had subsequent BA after failure of atherectomy alone. </p> </section> <section id="CD006680-sec-0067"> <h3 class="title" id="CD006680-sec-0067">Potential biases in the review process</h3> <p>Despite carrying out a thorough unrestricted search, our review process identified only seven trials of varying size, so it is difficult to assess the impact of reporting bias. </p> <p>Three trials treated more than one vessel per participant or limb (<a href="./references#CD006680-bbs2-0001" title="DattiloR , HimmelsteinSI , CuffRF . The COMPLIANCE 360 trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. Journal of Invasive Cardiology2014;26(8):355-60. ">Dattilo 2014</a>; <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a>; <a href="./references#CD006680-bbs2-0005" title="ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE , et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the calcium 360 randomized pilot trial. Journal of Endovascular Therapy2012;19(4):480-8. ShammasNW , LamR , MustaphaJ , EllichmanJ , AggarwalaG , RiveraE . Orbital atherectomy and balloon angioplasty vs. balloon angioplasty alone in critical limb ischemia: results of the CALCIUM 360 trial. Journal of Vascular and Interventional Radiology2013;24(1):145.e2-3. ShammasNWM . Six-month outcomes of prospective, randomized CALCIUM 360 study demonstrate the advantages of plaque modification with the orbital technology versus treatment with balloon angioplasty in patients with critical limb ischemia. Journal of the American College of Cardiology2011;58(20 Suppl 1):B154. ">Shammas 2012</a>). Failure of patency of any of the treated vessels increases the chances that other treated vessels will cease to be patent, so these observations will be correlated. It is possible, therefore, that the outcomes of these trials are given greater weight in the meta‐analysis than is appropriate in the analysis of six‐month and 12‐month patency. As both the angioplasty and atherectomy arms of these trials included multiple vessels per participant, it is unlikely that the magnitude of the observed effect has been affected significantly, though our degree of confidence in this effect may be overstated. </p> <p>There was some variation in whether trials collected target lesion revascularisation data or target vessel revascularisation data, or both. Upon discussion, we made the decision to collect target vessel revascularisation, as we felt this allowed us to perform the fairest comparison between all studies. Similarly, there was variation between trials in outcome definitions, with studies collecting primary patency rates or occlusion rates. Given the inter‐trial variation for the definitions between the two, we only included studies that collected 'primary patency' in the meta‐analysis. </p> </section> <section id="CD006680-sec-0068"> <h3 class="title" id="CD006680-sec-0068">Agreements and disagreements with other studies or reviews</h3> <p>This is an update of a previous Cochrane Review of atherectomy for PAD (<a href="./references#CD006680-bbs2-0066" title="AmblerGK , RadwanR , HayesPD , TwineCP . Atherectomy for peripheral arterial disease. Cochrane Database of Systematic Reviews2014, Issue 3. Art. No: CD006680. [DOI: 10.1002/14651858.CD006680.pub2]">Ambler 2014</a>). Very little further evidence exists in the literature for the use of atherectomy in peripheral vascular disease since the last review. This may in part be due to NICE guidelines recommending against the use of atherectomy devices unless in clinical trials (<a href="./references#CD006680-bbs2-0052" title="National Institute for Health and Care Excellence. Percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices [IPG380]. Available at: www.nice.org.uk/guidance/IPG3802011.">NICE 2011</a>). </p> <p><a href="./references#CD006680-bbs2-0029" title="AkkusNI , AbdulbakiA , JimenezE , TandonN . Atherectomy devices: technology update. Med Devices (Auckl)2014;8:1-10. [DOI: 10.2147/MDER.S50594]">Akkus 2014</a> performed a review of atherectomy devices, and argued that different types of atherectomy devices should be chosen to treat the most appropriate types of lesion in order to get the best possible clinical outcomes. The review looked at several studies, including the <a href="./references#CD006680-bbs2-0063" title="RamaiahV , GammonR , KieszS , CardenasJ , RunyonJP , FailP , et al, on behalf of the TALON Registry. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection. Journal of Endovascular Therapy2006;13(5):592-602.">TALON Registry 2006</a>, <a href="./references#CD006680-bbs2-0033" title="ReifartN , VandormaelM , KrajcarM , GöhringS , PreuslerW , SchwarzF , et al. Randomized comparison of angioplasty of complex coronary lesions at a single center. Excimer Laser, Rotational Atherectomy, and Balloon Angioplasty Comparison (ERBAC) Study. Circulation1997;96(1):91-8.">ERBAC 1997</a>, and <a href="./references#CD006680-bbs2-0050" title="McKinseyJF , GoldsteinL , KhanHU , GrahamA , RezeyatC , MorrisseyNJ , et al. Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions. Annals of Surgery2008;248(4):519-28.">McKinsey 2008</a>. <a href="./references#CD006680-bbs2-0046" title="KimTH , KatsetosM , DahalK , AzrinM , LeeJ . Use of rotational atherectomy for reducing significant dissection in treating de novo femoropopliteal steno-occlusive disease after balloon angioplasty. Journal of Geriatric Cardiology2018;15:254-60.">Kim 2018</a> examined dissection rates in atherectomy after BA, and similarly found dissection rates were reduced compared to angioplasty alone. However, this benefit alone does not justify the use of atherectomy over BA. <a href="./references#CD006680-bbs2-0053" title="RamkumarN , Martinez-CamblorP , ColumboJA , OsborneNH , GoodneyPP , O'MalleyAJ . Adverse events after atherectomy: analyzing long-term outcomes of endovascular lower extremity revascularization techniques. Journal of the American Heart Association2019;8(12):e012081.">Ramkumar 2019</a> studied five‐year clinical outcomes of atherectomy compared to other endovascular interventions using the Medicare‐linked VQI (Vascular Quality Initiative) registry for endovascular interventions from 2010 to 2015. They found an increased risk of any amputation in people treated with atherectomy compared to BA, and found that people who had atherectomy had a higher risk of major amputation, any amputation and major adverse limb event compared to stenting. </p> <p>Atherectomy has been more thoroughly investigated in the coronary arteries. The ORBIT II trial looked at the three‐year outcomes of de novo, severely calcified coronary lesions treated with a coronary orbital atherectomy system prior to stenting (<a href="./references#CD006680-bbs2-0048" title="LeeM , GenereuxP , ShlofmitzR , PhillipsonD , AnoseBM , MartinsenBJ , et al. Orbital atherectomy for treating de novo, severely calcified coronary lesions: 3-year results of the pivotal ORBIT II trial. Cardiovascular Revascularization Medicine2017;18:261-4.">Lee 2017</a>). This study found a lower rate of adverse ischaemic events compared to historical controls. However the ROTAXUS trial, which examined paclitaxel‐eluting stents with or without atherectomy, found no difference in primary patency at nine months between the two arms (<a href="./references#CD006680-bbs2-0028" title="Abdel-WahabM , RichardtG , Joachim ButtnerH , ToelgR , GeistV , MeinertzT , et al. High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial. ACC Cardiovascular Intervention January 2013;6:10-9.">Abdel‐Wahab 2013</a>). </p> <p>Balloon angioplasty for peripheral vascular disease is widely practised, has a clear evidence base and is constantly evolving, with the use of covered stents and drug‐eluting devices (<a href="./references#CD006680-bbs2-0058" title="SchroederH , WernerM , MeyerDR , ReimerP , KrugerK , JaffMR , et al. Low-dose Paclitaxel-coated versus uncoated percutaneous transluminal balloon angioplasty for femoropopliteal peripheral artery disease: one-year results of the ILLUMENATE European randomized clinical trial (randomized trial of a novel paclitaxel-coated percutaneous angioplasty balloon). Circulation2017;135:2227-36.">Schroeder 2017</a>; <a href="./references#CD006680-bbs2-0064" title="NorgrenL , HiattWR , DormandyJA , NehlerMR , HarrisKA , FowkesFG , et al, on behalf of the TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. International Angiology2007;26(2):81-157.">TASC II 2007</a>). As the technique has evolved, so has the evidence base for its place compared to exercise therapy and bypass surgery (<a href="./references#CD006680-bbs2-0038" title="FuX , ZhangZ , LiangK , ShiS , WangG , ZhangK , et al. Angioplasty versus bypass surgery in patients with critical limb ischemia: a meta-analysis. International Journal of Clinical and Experimental Medicine2015;8:10595-602.">Fu 2015</a>; <a href="./references#CD006680-bbs2-0045" title="KayssiA , Al-AtassiT , OreopoulosG , Roche-NagleG , TanKT , RajanDK . Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs. Cochrane Database of Systematic Reviews2016, Issue 8. Art. No: CD011319. [DOI: 10.1002/14651858.CD011319.pub2]">Kayssi 2016</a>). <a href="./references#CD006680-bbs2-0038" title="FuX , ZhangZ , LiangK , ShiS , WangG , ZhangK , et al. Angioplasty versus bypass surgery in patients with critical limb ischemia: a meta-analysis. International Journal of Clinical and Experimental Medicine2015;8:10595-602.">Fu 2015</a> demonstrated equivalent results to surgical bypass procedures for treating critical limb ischaemia at five‐year follow‐up for amputation‐free survival, target vessel revascularisation, leg amputation and overall mortality. A cohort study examining subintimal angioplasty versus atherectomy for the treatment of occlusive lesions in lower limbs found that angioplasty appeared superior for both patency and limb salvage at 24 months (<a href="./references#CD006680-bbs2-0043" title="IndesJE , ShahHJ , JonkerFH , OhkiT , VeithFJ , LipsitzEC . Subintimal angioplasty is superior to SilverHawk atherectomy for the treatment of occlusive lesions of the lower extremities. Journal of Endovascular Therapy2010;17(2):243-50.">Indes 2010</a>). <a href="./references#CD006680-bbs2-0006" title="TielbeekAV , VroegindeweijD , ButhJ , LandmanGH . Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. Journal of Vascular and Interventional Radiology1996;7(6):837-44. TielbeekAV , VroegindeweijD , ButhJ , ScholFP , MaliWP . Comparison of intravascular ultrasonography and intraarterial digital subtraction angiography after directional atherectomy of short lesions in femoropopliteal arteries. Journal of Vascular Surgery1996;23(3):436-45. VroegindeweijD , KemperFJ , TielbeekAV , ButhJ , LandmanG . Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. European Journal of Vascular Surgery1992;6(2):164-71. VroegindeweijD , KemperFJ , TielbeekAV , LandmanG , ButhJ . Recurrence of stenoses following balloon angioplasty and atherectomy of the femoropopliteal segment. A randomized comparative one year follow-up study using color flow duplex. In: European Society for Vascular Surgery 5th Annual Meeting. Warsaw, Poland, 1991:72. VroegindeweijD , TielbeekAV , ButhJ , ScholFP , HopWC , LandmanGH . Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. Journal of Vascular Surgery1995;21(2):255-68; discussion 268-9. ">Vroegindeweij 1995</a> performed a post hoc analysis to assess the effect of lesion length on patency. Using life‐table analysis, they showed that atherectomy was equivalent to BA for short lesions (&lt; 2 cm), but for longer lesions, long‐term patency was significantly better following BA (P = 0.007). </p> <p>Stenting in PAD has been the focus of significant attention. Several randomised trials have compared stenting to angioplasty alone, the majority favouring stenting (<a href="./references#CD006680-bbs2-0031" title="DakeMD , AnselGM , JaffMR , OhkiT , SaxonRR , SmouseHB , et al, Zilver PTX Investigators. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circulation. Cardiovascular Interventions2011;4(5):495-504.">Dake 2011</a>; <a href="./references#CD006680-bbs2-0061" title="SpreenMI , MartensJM , KnippenbergB , vanDijkLC , deVriesJPM , VosJA , et al. Long-term follow-up of the PADI trial: percutaneous transluminal angioplasty versus drug-eluting stents for infrapopliteal lesions in critical limb ischemia. Journal of the American Heart Association2017;6(4):e004877.">Spreen 2017</a>). <a href="./references#CD006680-bbs2-0061" title="SpreenMI , MartensJM , KnippenbergB , vanDijkLC , deVriesJPM , VosJA , et al. Long-term follow-up of the PADI trial: percutaneous transluminal angioplasty versus drug-eluting stents for infrapopliteal lesions in critical limb ischemia. Journal of the American Heart Association2017;6(4):e004877.">Spreen 2017</a> found that drug‐eluting stents were associated with significantly lower amputation and event‐free rates at five years compared with percutaneous transluminal angioplasty. <a href="./references#CD006680-bbs2-0051" title="MurphyTP , CutlipDE , RegensteinerJG , MohlerER , CohenDJ , ReynoldsMR , et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: a randomized clinical trial. Journal of the American College of Cardiology2015;65:999-1009.">Murphy 2015</a> compared supervised exercise, primary stenting and optimal medical care, and found that stenting and exercise had either superior or equivalent outcomes for both walking distance and quality of life at 18 months. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006680-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD006680-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full#CD006680-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006680-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full#CD006680-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006680-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full#CD006680-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Atherectomy versus balloon angioplasty, Outcome 1: 6‐month primary patency" data-id="CD006680-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Atherectomy versus balloon angioplasty, Outcome 1: 6‐month primary patency</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Atherectomy versus balloon angioplasty, Outcome 2: 12‐month primary patency" data-id="CD006680-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Atherectomy versus balloon angioplasty, Outcome 2: 12‐month primary patency </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Atherectomy versus balloon angioplasty, Outcome 3: Mortality" data-id="CD006680-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Atherectomy versus balloon angioplasty, Outcome 3: Mortality</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Atherectomy versus balloon angioplasty, Outcome 4: Initial technical failure rates" data-id="CD006680-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Atherectomy versus balloon angioplasty, Outcome 4: Initial technical failure rates </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Atherectomy versus balloon angioplasty, Outcome 5: Bailout stenting" data-id="CD006680-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Atherectomy versus balloon angioplasty, Outcome 5: Bailout stenting</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Atherectomy versus balloon angioplasty, Outcome 6: Balloon inflation pressure" data-id="CD006680-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Atherectomy versus balloon angioplasty, Outcome 6: Balloon inflation pressure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Atherectomy versus balloon angioplasty, Outcome 7: Target vessel revascularisation at 6 months" data-id="CD006680-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Atherectomy versus balloon angioplasty, Outcome 7: Target vessel revascularisation at 6 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Atherectomy versus balloon angioplasty, Outcome 8: Target vessel revascularisation at 12 months" data-id="CD006680-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Atherectomy versus balloon angioplasty, Outcome 8: Target vessel revascularisation at 12 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Atherectomy versus balloon angioplasty, Outcome 9: Complication rate" data-id="CD006680-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Atherectomy versus balloon angioplasty, Outcome 9: Complication rate</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Atherectomy versus balloon angioplasty, Outcome 10: Embolisation" data-id="CD006680-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Atherectomy versus balloon angioplasty, Outcome 10: Embolisation</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Atherectomy versus balloon angioplasty, Outcome 11: Dissections" data-id="CD006680-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Atherectomy versus balloon angioplasty, Outcome 11: Dissections</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Atherectomy versus balloon angioplasty, Outcome 12: Amputation" data-id="CD006680-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Atherectomy versus balloon angioplasty, Outcome 12: Amputation</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Atherectomy +/‐ bailout stenting versus primary stenting, Outcome 1: Mortality" data-id="CD006680-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Atherectomy +/‐ bailout stenting versus primary stenting, Outcome 1: Mortality </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Atherectomy +/‐ bailout stenting versus primary stenting, Outcome 2: Cardiovascular events" data-id="CD006680-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Atherectomy +/‐ bailout stenting versus primary stenting, Outcome 2: Cardiovascular events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Atherectomy +/‐ bailout stenting versus primary stenting, Outcome 3: Initial technical failure rates" data-id="CD006680-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Atherectomy +/‐ bailout stenting versus primary stenting, Outcome 3: Initial technical failure rates </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Atherectomy +/‐ bailout stenting versus primary stenting, Outcome 4: Target vessel revascularisation at 6 months" data-id="CD006680-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Atherectomy +/‐ bailout stenting versus primary stenting, Outcome 4: Target vessel revascularisation at 6 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Atherectomy +/‐ bailout stenting versus primary stenting, Outcome 5: Target vessel revascularisation at 24 months" data-id="CD006680-fig-0020" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Atherectomy +/‐ bailout stenting versus primary stenting, Outcome 5: Target vessel revascularisation at 24 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Atherectomy +/‐ bailout stenting versus primary stenting, Outcome 6: Complication rate" data-id="CD006680-fig-0021" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Atherectomy +/‐ bailout stenting versus primary stenting, Outcome 6: Complication rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006680-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/urn:x-wiley:14651858:media:CD006680:CD006680-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Atherectomy +/‐ bailout stenting versus primary stenting, Outcome 7: Amputation" data-id="CD006680-fig-0022" src="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_t/tCD006680-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Atherectomy +/‐ bailout stenting versus primary stenting, Outcome 7: Amputation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/media/CDSR/CD006680/image_n/nCD006680-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006680-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Atherectomy compared to balloon angioplasty for peripheral arterial disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Atherectomy compared to BA for PAD</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with PAD<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> atherectomy<br/><b>Comparison:</b> BA </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with BA</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with atherectomy</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Primary patency</b> </p> <p>(follow‐up: 6 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>186<br/>(3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.06 (0.94 to 1.20)</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>575 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>609 per 1000 (540 to 690)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Primary patency</b> </p> <p>(follow‐up: 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>149<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.20 (0.78 to 1.84)</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>671 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>805 per 1000 (524 to 1000)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality</b> </p> <p>(follow‐up: 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>210<br/>(3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.50<br/>(0.10 to 2.66) </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51 per 1000 (10 to 271)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Fatal and non‐fatal cardiovascular events</b> </p> <p>(follow‐up: 24 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>160<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD006680-bbs2-0007" title="NCT01366482. Atherectomy followed by a drug coated balloon to treat peripheral arterial disease (DEFINITIVE AR). clinicaltrials.gov/show/NCT01366482 (first posted 6 June 2011). ZellerT , LanghoffR , Rocha-SinghKJ , JaffMR , BlessingE , Amann-VestiB , et al. Directional atherectomy followed by a Paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR Study. Circulation: Cardiovascular Interventions2017;10(9):e004848. [DOI: 10.1161/circinterventions.116.004848]">Zeller 2017</a> reported cardiac failure and acute coronary syndrome as causes of death at 24 months, but it was unclear for which participants in which arms this was accountable for. <a href="./references#CD006680-bbs2-0004" title="CoinerD , DippelE , JerinM , ShammasG , ShammasN . Percutaneous lower extremity arterial interventions using balloon angioplasty versus silverhawk atherectomy: results of the SMARTHAWK randomized trial. Catheterization and Cardiovascular Interventions2009;73:S21. CoinerD , DippelE , JerinM , ShammasG , ShammasN . Walking impairment questionnaire, ankle-brachial index and Rutherford-Baker class in patients undergoing angioplasty versus Silverhawk atherectomy: results from the smarthawk randomized trial. Catheterization and Cardiovascular Interventions2009;73:S42. ShammasNW , CoinerD , ShammasG , JerinM . Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. International Journal of Angiology2011;20(2):95-100. ShammasNW , CoinerD , ShammasGA , DippelEJ , ChristensenL , JerinM . Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. Journal of Vascular and Interventional Radiology2011;22(9):1223-8. ">Shammas 2011</a> declared embolic stroke and myocardial infarction to be secondary outcomes, but no events were recorded in either arm </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>TVR</b> </p> <p>(follow‐up: 6 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>136<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.51<br/>(0.06 to 4.42) </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36 per 1000 (4 to 311)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>TVR</b> </p> <p>(follow‐up: 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>176<br/>(3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.59<br/>(0.25 to 1.42) </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>140 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82 per 1000 (35 to 198)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Complication rates</b> </p> <p>(follow‐up: 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>387<br/>(6 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.69</p> <p>(0.28 to 1.68)</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>219 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151 per 1000 (61 to 367)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>BA</b> : balloon angioplasty; <b>CI:</b> confidence interval; <b>PAD</b> : peripheral arterial disease; <b>RR:</b> risk ratio; <b>TVR</b>: target vessel revascularisation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup> We downgraded by three steps due to risk of bias (lack of blinding and high rates of attrition); imprecision (small trials with few participants and events); and inconsistency (heterogeneity). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Atherectomy compared to balloon angioplasty for peripheral arterial disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full#CD006680-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006680-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Atherectomy compared to balloon angioplasty with primary stenting for peripheral arterial disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Atherectomy compared to BA and primary stenting for PAD</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with PAD<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> atherectomy<br/><b>Comparison:</b> BA with primary stenting </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with BA with primary stenting</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with atherectomy</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Primary patency</b> </p> <p>(follow‐up 6 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Primary patency</b> </p> <p>(follow‐up 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>Not reported for this comparison</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Mortality</b> </p> <p>(follow‐up: 24 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>155<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.38<br/>(0.04 to 3.23) </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 per 1000 (2 to 129)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Fatal and non‐fatal cardiovascular events</b> </p> <p>(follow‐up: 24 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>155<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.38 (0.04, 3.23)</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> reported 4 deaths at 24 months (3 deaths in the drug‐eluting balloon and stent arm and 1 death in the plain balloon and stent arm) which they attributed to underlying cardiovascular disease, but no specific causes were stated. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>TVR</b> </p> <p>(follow‐up: 6 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>155<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.27<br/>(0.95 to 5.46) </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>182 per 1000 (76 to 437)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>TVR</b> </p> <p>(follow‐up: 24 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>155<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.05<br/>(0.96 to 4.37) </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>240 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>492 per 1000 (230 to 1000)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Complication rates</b> </p> <p>(follow‐up: 24 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>155<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 7.04<br/>(0.80 to 62.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD006680-bbs2-0003" title="NCT00986752. Efficacy study of stenting, paclitaxel eluting balloon or atherectomy to treat peripheral artery disease (ISAR-STATH). clinicaltrials.gov/show/NCT00986752 (first posted 30 September 2009). OttI , CasseseS , GrohaP , SteppichB , HadamitzkyM , IbrahimT , et al. Randomized comparison of Paclitaxel-eluting balloon and stenting versus plain balloon plus stenting versus directional atherectomy for femoral artery disease (ISAR-STATH). Circulation2017;135(23):2218-26. ">Ott 2017</a> reported 3 complications, all 3 of which were in the atherectomy arm: 2 vessel perforations and 1 flow‐limiting dissection. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>BA</b> : balloon angioplasty <b>CI:</b> confidence interval; <b>PAD</b> : peripheral arterial disease; <b>RR</b> : risk ratio; <b>TVR</b>: target vessel revascularisation </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup> We downgraded by three steps due to risk of bias (inadequate blinding and high rates of attrition); and imprecision (small trial size, few participants and events, and wide confidence intervals). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Atherectomy compared to balloon angioplasty with primary stenting for peripheral arterial disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/full#CD006680-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006680-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Atherectomy versus balloon angioplasty</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 6‐month primary patency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.94, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.51, 1.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Drug‐eluting balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.94, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 12‐month primary patency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.78, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [0.90, 2.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Drug‐eluting balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.86, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.10, 2.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.04, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Drug‐eluting balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.25 [0.21, 24.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Initial technical failure rates <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>425</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.22, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.20, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Drug‐eluting balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.12, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Bailout stenting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.09, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.07, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 Drug‐eluting balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.01, 4.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Balloon inflation pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.68 [‐5.36, ‐2.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Target vessel revascularisation at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.06, 4.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.01, 2.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 Drug‐eluting balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.17, 8.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Target vessel revascularisation at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.25, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.15, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 Drug‐eluting balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.22, 3.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Complication rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.28, 1.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 Balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.22, 2.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.2 Drug‐eluting balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.27, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Embolisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.51 [0.64, 9.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 Plain balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.84 [0.39, 8.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 Drug‐eluting balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.86 [0.42, 148.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Dissections <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.14, 0.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.1 Plain balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.16, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.2 Drug‐eluting balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Amputation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.1 Balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.2 Drug‐eluting balloon angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Atherectomy versus balloon angioplasty</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006680-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Atherectomy +/‐ bailout stenting versus primary stenting</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.04, 3.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Plain balloon plus stent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.03, 14.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Drug‐eluting balloon plus stent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.01, 4.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Cardiovascular events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.04, 3.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Plain balloon plus stent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.03, 14.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Drug‐eluting balloon plus stent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.01, 4.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Initial technical failure rates <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Plain balloon plus stent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Drug‐eluting balloon plus stent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Target vessel revascularisation at 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.27 [0.95, 5.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Plain balloon plus stent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.93 [0.61, 6.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Drug‐eluting balloon plus stent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.86 [0.74, 11.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Target vessel revascularisation at 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.05 [0.96, 4.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Plain balloon plus stent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.85, 2.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.2 Drug‐eluting balloon plus stent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.18 [1.44, 7.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Complication rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.04 [0.80, 62.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Plain balloon plus stent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.46 [0.47, 190.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.2 Drug‐eluting balloon plus stent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.07 [0.21, 120.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Amputation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.1 Plain balloon plus stent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.2 Drug‐eluting balloon plus stent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Atherectomy +/‐ bailout stenting versus primary stenting</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006680.pub3/references#CD006680-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006680.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006680-note-0009">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006680-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006680-note-0007">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD006680-note-0005">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD006680-note-0008">Bahasa Malaysia</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006680\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006680\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006680\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006680\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006680\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UiM8QuvV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006680.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006680.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006680.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006680.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006680.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718982154"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006680.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718982158"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006680.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ddd9fb9f71be5',t:'MTc0MDcxODk4Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 